<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet href="https://rss.buzzsprout.com/styles.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:psc="http://podlove.org/simple-chapters" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <atom:link href="https://feeds.buzzsprout.com/2173407.rss" rel="self" type="application/rss+xml" />
  <atom:link href="https://pubsubhubbub.appspot.com/" rel="hub" xmlns="http://www.w3.org/2005/Atom" />
  <title>The Diagnostic Minute</title>

  <lastBuildDate>Sat, 07 Mar 2026 22:58:12 -0500</lastBuildDate>
  <link>https://www.buzzsprout.com/2173407</link>
  <language>en-us</language>
  <copyright>© 2026 The Diagnostic Minute</copyright>
  <podcast:locked>yes</podcast:locked>
    <podcast:guid>26197eda-1b10-568d-a578-5f927d964ee8</podcast:guid>
  <itunes:author>EssentialPathology, NNMI</itunes:author>
  <itunes:type>episodic</itunes:type>
  <itunes:explicit>false</itunes:explicit>
  <description><![CDATA[<p>The Diagnostic Minute delivers concise and pragmatic diagnostic insights in a scholarly format. Each episode features a specific diagnostic topic in a succinct and clear manner in just a few minutes. Our team of experts draws from their extensive clinical experience and the latest evidence-based research to provide you with the most up-to-date information. (www.essentialpathology.info).<br><br><b>Disclaimer&nbsp;</b></p><p>&nbsp;</p><p>The content of "The Diagnostic Minute" is intended for educational and training purposes only. The information provided in this podcast is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The podcast is not a substitute for professional medical advice, diagnosis, or treatment.&nbsp; EssentialPathology, NNMI, LLC, and its affiliates do not endorse any specific treatment, drug, test, or medical procedure discussed in the podcast.</p><p>&nbsp;</p><p>Listeners should not rely on the information provided in the podcast to make medical decisions or justify any related test. Listeners should consult a qualified healthcare professional before making any medical decisions or taking any action based on the information provided in the podcast.</p><p>&nbsp;</p><p>Listeners are responsible for their use of the information provided in the podcast, and they agree to use it at their own risk. EssentialPathology, NNMI, LLC, and its affiliates shall not be held liable for any use or misuse of the information provided in the podcast. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
  <generator>Buzzsprout (https://www.buzzsprout.com)</generator>
  <itunes:owner>
    <itunes:name>EssentialPathology, NNMI</itunes:name>
  </itunes:owner>
  <image>
     <url>https://storage.buzzsprout.com/q379xwt5uy447loqcvifyda3o7w6?.jpg</url>
     <title>The Diagnostic Minute</title>
     <link></link>
  </image>
  <itunes:image href="https://storage.buzzsprout.com/q379xwt5uy447loqcvifyda3o7w6?.jpg" />
  <itunes:category text="Health &amp; Fitness">
    <itunes:category text="Medicine" />
  </itunes:category>
  <item>
    <itunes:title>Mini-Review:  A Path to Personal Private AI model (00:18:47)</itunes:title>
    <title>Mini-Review:  A Path to Personal Private AI model (00:18:47)</title>
    <itunes:summary><![CDATA[Welcome to "You &amp; AI" by EssentialPathology. This short series of Building Your Local AI is designed specifically for non-technical and low-technical professionals. This critical review outlines a comprehensive transition toward local Large Language Models, highlighting a shift from cloud-dependency to private, cost-free, and offline AI environments. The text follows a structured educational path, ]]></itunes:summary>
    <description><![CDATA[<p>Welcome to &quot;You &amp; AI&quot; by EssentialPathology. This short series of <b>Building Your Local AI</b> is designed specifically for non-technical and low-technical professionals. This critical review outlines a comprehensive transition toward <b>local Large Language Models</b>, highlighting a shift from cloud-dependency to <b>private, cost-free, and offline AI</b> environments. The text follows a structured educational path,</p>]]></description>
    <content:encoded><![CDATA[<p>Welcome to &quot;You &amp; AI&quot; by EssentialPathology. This short series of <b>Building Your Local AI</b> is designed specifically for non-technical and low-technical professionals. This critical review outlines a comprehensive transition toward <b>local Large Language Models</b>, highlighting a shift from cloud-dependency to <b>private, cost-free, and offline AI</b> environments. The text follows a structured educational path,</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18801240-mini-review-a-path-to-personal-private-ai-model-00-18-47.mp3" length="13554799" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18801240</guid>
    <pubDate>Fri, 06 Mar 2026 08:00:00 -0500</pubDate>
    <itunes:duration>1127</itunes:duration>
    <itunes:keywords>Artificial intelligence (AI), language models (LM), technologies, </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>2</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Build Local AI Language Model - 01 (00:20:54)</itunes:title>
    <title>Build Local AI Language Model - 01 (00:20:54)</title>
    <itunes:summary><![CDATA[Welcome to "You &amp; AI" by EssentialPathology. This short series of Building Your Local AI is designed specifically for non-technical and low-technical professionals. The goal is simple:  focus on incredibly user-friendly tool that does the heavy lifting, paired with an easy-to-use graphical interface and avoid overwhelming you with complex code or heavy developer tools like Docker or Python scripts.  ]]></itunes:summary>
    <description><![CDATA[<p>Welcome to &quot;You &amp; AI&quot; by EssentialPathology. This short series of <b>Building Your Local AI</b> is designed specifically for non-technical and low-technical professionals. The goal is simple:  focus on incredibly user-friendly tool that does the heavy lifting, paired with an easy-to-use graphical interface and avoid overwhelming you with complex code or heavy developer tools like Docker or Python scripts. </p>]]></description>
    <content:encoded><![CDATA[<p>Welcome to &quot;You &amp; AI&quot; by EssentialPathology. This short series of <b>Building Your Local AI</b> is designed specifically for non-technical and low-technical professionals. The goal is simple:  focus on incredibly user-friendly tool that does the heavy lifting, paired with an easy-to-use graphical interface and avoid overwhelming you with complex code or heavy developer tools like Docker or Python scripts. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18801187-build-local-ai-language-model-01-00-20-54.mp3" length="15082932" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18801187</guid>
    <pubDate>Fri, 06 Mar 2026 08:00:00 -0500</pubDate>
    <itunes:duration>1254</itunes:duration>
    <itunes:keywords>Artificial intelligence (AI), language models (LM), technologies, </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>1</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Ovarian Stromal Tumors (00:15:49)</itunes:title>
    <title>Mini-Review: Ovarian Stromal Tumors (00:15:49)</title>
    <itunes:summary><![CDATA[Ovarian Stromal Tumors Ovarian fibroma  Thecoma  Luteinized thecoma associated with sclerosing peritonitis  Sclerosing stromal tumor  Microcystic stromal tumor  Signet-ring stromal tumor  Leydig cell tumor  Steroid cell tumor  Ovarian fibrosarcoma  Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and...]]></itunes:summary>
    <description><![CDATA[<p><b>Ovarian Stromal Tumors</b></p><ul><li>Ovarian fibroma  </li><li>Thecoma  </li><li>Luteinized thecoma associated with sclerosing peritonitis  </li><li>Sclerosing stromal tumor  </li><li>Microcystic stromal tumor  </li><li>Signet-ring stromal tumor  </li><li>Leydig cell tumor  </li><li>Steroid cell tumor  </li><li>Ovarian fibrosarcoma  </li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Ovarian Stromal Tumors</b></p><ul><li>Ovarian fibroma  </li><li>Thecoma  </li><li>Luteinized thecoma associated with sclerosing peritonitis  </li><li>Sclerosing stromal tumor  </li><li>Microcystic stromal tumor  </li><li>Signet-ring stromal tumor  </li><li>Leydig cell tumor  </li><li>Steroid cell tumor  </li><li>Ovarian fibrosarcoma  </li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18603021-mini-review-ovarian-stromal-tumors-00-15-49.mp3" length="11413773" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18603021</guid>
    <pubDate>Sat, 31 Jan 2026 22:00:00 -0500</pubDate>
    <itunes:duration>949</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, mini-review, Gyn, mLearning. </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>23</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Ovarian Sex-Cord Stromal Tumors (00:18:43)</itunes:title>
    <title>Mini-Review: Ovarian Sex-Cord Stromal Tumors (00:18:43)</title>
    <itunes:summary><![CDATA[Ovarian Sex-Cord Tumors Adult granulosa cell tumor  Juvenile granulosa cell tumor  Sertoli cell tumor  Sex cord tumor with annular tubules  Mixed sex cord-stromal tumorsSertoli-Leydig cell tumor Sex cord-stromal tumor NOS Gynandroblastoma Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at ...]]></itunes:summary>
    <description><![CDATA[<p><b>Ovarian Sex-Cord Tumors</b></p><ul><li>Adult granulosa cell tumor  </li><li>Juvenile granulosa cell tumor  </li><li>Sertoli cell tumor  </li><li>Sex cord tumor with annular tubules  </li><li>Mixed sex cord-stromal tumors</li><li>Sertoli-Leydig cell tumor </li><li>Sex cord-stromal tumor NOS </li><li>Gynandroblastoma </li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Ovarian Sex-Cord Tumors</b></p><ul><li>Adult granulosa cell tumor  </li><li>Juvenile granulosa cell tumor  </li><li>Sertoli cell tumor  </li><li>Sex cord tumor with annular tubules  </li><li>Mixed sex cord-stromal tumors</li><li>Sertoli-Leydig cell tumor </li><li>Sex cord-stromal tumor NOS </li><li>Gynandroblastoma </li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18603007-mini-review-ovarian-sex-cord-stromal-tumors-00-18-43.mp3" length="13512468" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18603007</guid>
    <pubDate>Sat, 31 Jan 2026 22:00:00 -0500</pubDate>
    <itunes:duration>1123</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, mini-review, Gyn, mLearning. </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>22</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Non-neoplastic Lesions of the Ovary (00:14:20)</itunes:title>
    <title>Mini-Review: Non-neoplastic Lesions of the Ovary (00:14:20)</title>
    <itunes:summary><![CDATA[Non-neoplastic Lesions of the Ovary Large solitary luteinized follicle cyst Hyperreactio luteinalis Autoimmune OophoritisEndometriosis (and Deciduosis)Stromal Hyperplasia and HyperthecosisMassive Edema and Fibromatosis   Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podca...]]></itunes:summary>
    <description><![CDATA[<p><b>Non-neoplastic Lesions of the Ovary</b></p><ul><li>Large solitary luteinized follicle cyst </li><li>Hyperreactio luteinalis </li><li>Autoimmune Oophoritis</li><li>Endometriosis (and Deciduosis)</li><li>Stromal Hyperplasia and Hyperthecosis</li><li>Massive Edema and Fibromatosis </li></ul><p><br/></p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Non-neoplastic Lesions of the Ovary</b></p><ul><li>Large solitary luteinized follicle cyst </li><li>Hyperreactio luteinalis </li><li>Autoimmune Oophoritis</li><li>Endometriosis (and Deciduosis)</li><li>Stromal Hyperplasia and Hyperthecosis</li><li>Massive Edema and Fibromatosis </li></ul><p><br/></p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18602992-mini-review-non-neoplastic-lesions-of-the-ovary-00-14-20.mp3" length="10349257" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18602992</guid>
    <pubDate>Sat, 31 Jan 2026 21:00:00 -0500</pubDate>
    <itunes:duration>860</itunes:duration>
    <itunes:keywords>Pathology, non-neoplastic, mimics, ovary, mini-review, Gyn, mLearning. </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>21</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Dysgerminoma of the Ovary (00:02:45)</itunes:title>
    <title>Synopsis: Dysgerminoma of the Ovary (00:02:45)</title>
    <itunes:summary><![CDATA[Key Feature Summary of Ovarian Dysgerminoma Most common malignant ovarian germ cell tumorAdolescents and young adults (mean age 19)Solid, lobulated, fleshy white-tan massNests of polygonal cells separated by fibrous septaLymphocytic infiltrate within septaIHC: positive for OCT4, SALL4, and CD117 (KIT)Main differential diagnosis: lymphoma and solid yolk sac tumorDisclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full respo...]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary of Ovarian Dysgerminoma</b></p><ol><li>Most common malignant ovarian germ cell tumor</li><li>Adolescents and young adults (mean age 19)</li><li>Solid, lobulated, fleshy white-tan mass</li><li>Nests of polygonal cells separated by fibrous septa</li><li>Lymphocytic infiltrate within septa</li><li>IHC: positive for OCT4, SALL4, and CD117 (KIT)</li><li>Main differential diagnosis: lymphoma and solid yolk sac tumor</li></ol><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary of Ovarian Dysgerminoma</b></p><ol><li>Most common malignant ovarian germ cell tumor</li><li>Adolescents and young adults (mean age 19)</li><li>Solid, lobulated, fleshy white-tan mass</li><li>Nests of polygonal cells separated by fibrous septa</li><li>Lymphocytic infiltrate within septa</li><li>IHC: positive for OCT4, SALL4, and CD117 (KIT)</li><li>Main differential diagnosis: lymphoma and solid yolk sac tumor</li></ol><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589950-synopsis-dysgerminoma-of-the-ovary-00-02-45.mp3" length="2010003" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589950</guid>
    <pubDate>Thu, 29 Jan 2026 07:00:00 -0500</pubDate>
    <itunes:duration>165</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, mini-review, Gyn, mLearning </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>21</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Embryonal Carcinoma of the Ovary (00:02:30)</itunes:title>
    <title>Synopsis: Embryonal Carcinoma of the Ovary (00:02:30)</title>
    <itunes:summary><![CDATA[Key Feature Summary of Ovarian Embryonal Carcinoma Rare in pure form; usually mixedChildren and young adultsElevated hCG and/or AFPSolid, hemorrhagic, and necrotic massLarge pleomorphic cells with prominent nucleoliIHC: positive for CD30, OCT4, and SALL4Main differential diagnosis: dysgerminoma and yolk sac tumorDisclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provide...]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary of Ovarian Embryonal Carcinoma</b></p><ol><li>Rare in pure form; usually mixed</li><li>Children and young adults</li><li>Elevated hCG and/or AFP</li><li>Solid, hemorrhagic, and necrotic mass</li><li>Large pleomorphic cells with prominent nucleoli</li><li>IHC: positive for CD30, OCT4, and SALL4</li><li>Main differential diagnosis: dysgerminoma and yolk sac tumor</li></ol><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary of Ovarian Embryonal Carcinoma</b></p><ol><li>Rare in pure form; usually mixed</li><li>Children and young adults</li><li>Elevated hCG and/or AFP</li><li>Solid, hemorrhagic, and necrotic mass</li><li>Large pleomorphic cells with prominent nucleoli</li><li>IHC: positive for CD30, OCT4, and SALL4</li><li>Main differential diagnosis: dysgerminoma and yolk sac tumor</li></ol><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589936-synopsis-embryonal-carcinoma-of-the-ovary-00-02-30.mp3" length="1836357" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589936</guid>
    <pubDate>Thu, 29 Jan 2026 07:00:00 -0500</pubDate>
    <itunes:duration>150</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, mini-review, Gyn, mLearning</itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>20</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Immature Teratoma of the Ovary (00:02:30)</itunes:title>
    <title>Synopsis: Immature Teratoma of the Ovary (00:02:30)</title>
    <itunes:summary><![CDATA[Key Feature Summary of Ovarian Immature Teratoma Malignant tumor containing embryonic-type tissuesTypically large, solid-and-cystic mass with necrosisPresence of immature neuroepithelial tubules and rosettesGrading based on the quantity of immature neuroectodermFrequent mitoses and single-cell apoptosisAssociated with elevated serum alpha-fetoproteinPotential for extraovarian spread, such as gliomatosis peritoneiDisclaimer The content of "The Diagnostic Minute" is intended for educational and...]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary of Ovarian Immature Teratoma</b></p><ul><li>Malignant tumor containing embryonic-type tissues</li><li>Typically large, solid-and-cystic mass with necrosis</li><li>Presence of immature neuroepithelial tubules and rosettes</li><li>Grading based on the quantity of immature neuroectoderm</li><li>Frequent mitoses and single-cell apoptosis</li><li>Associated with elevated serum alpha-fetoprotein</li><li>Potential for extraovarian spread, such as gliomatosis peritonei</li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary of Ovarian Immature Teratoma</b></p><ul><li>Malignant tumor containing embryonic-type tissues</li><li>Typically large, solid-and-cystic mass with necrosis</li><li>Presence of immature neuroepithelial tubules and rosettes</li><li>Grading based on the quantity of immature neuroectoderm</li><li>Frequent mitoses and single-cell apoptosis</li><li>Associated with elevated serum alpha-fetoprotein</li><li>Potential for extraovarian spread, such as gliomatosis peritonei</li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589914-synopsis-immature-teratoma-of-the-ovary-00-02-30.mp3" length="1830081" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589914</guid>
    <pubDate>Thu, 29 Jan 2026 07:00:00 -0500</pubDate>
    <itunes:duration>150</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, synopsis, Gyn, mLearning  </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>19</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Ledig Cell Tumor of the Ovary (00:01:56)</itunes:title>
    <title>Synopsis: Ledig Cell Tumor of the Ovary (00:01:56)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589883-synopsis-ledig-cell-tumor-of-the-ovary-00-01-56.mp3" length="1422569" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589883</guid>
    <pubDate>Thu, 29 Jan 2026 07:00:00 -0500</pubDate>
    <itunes:duration>116</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, synopsis, Gyn, mLearning.</itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>18</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Ovarian Mucinous Tumors (00:05:16)</itunes:title>
    <title>Mini-Review: Ovarian Mucinous Tumors (00:05:16)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589866-mini-review-ovarian-mucinous-tumors-00-05-16.mp3" length="3822800" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589866</guid>
    <pubDate>Thu, 29 Jan 2026 07:00:00 -0500</pubDate>
    <itunes:duration>316</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, mini-review, Gyn. </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>17</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Microcystic Stromal Tumor (MCST) of the Ovary (00:03:14)</itunes:title>
    <title>Mini-Review: Microcystic Stromal Tumor (MCST) of the Ovary (00:03:14)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589832-mini-review-microcystic-stromal-tumor-mcst-of-the-ovary-00-03-14.mp3" length="2358629" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589832</guid>
    <pubDate>Thu, 29 Jan 2026 07:00:00 -0500</pubDate>
    <itunes:duration>194</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, mini-review, Gyn. </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>16</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Ovarian Serous Borderline Tumors  (00:04:23)</itunes:title>
    <title>Mini-Review: Ovarian Serous Borderline Tumors  (00:04:23)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589819-mini-review-ovarian-serous-borderline-tumors-00-04-23.mp3" length="3188670" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589819</guid>
    <pubDate>Thu, 29 Jan 2026 07:00:00 -0500</pubDate>
    <itunes:duration>263</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, mini-review, Gyn. </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>15</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Teratomas of the Ovary (00:15:12)</itunes:title>
    <title>Mini-Review: Teratomas of the Ovary (00:15:12)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589810-mini-review-teratomas-of-the-ovary-00-15-12.mp3" length="10976795" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589810</guid>
    <pubDate>Thu, 29 Jan 2026 07:00:00 -0500</pubDate>
    <itunes:duration>912</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, mini-review, Gyn. </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>14</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Yolk Sac Tumor of the Ovary (00:02:30)</itunes:title>
    <title>Synopsis: Yolk Sac Tumor of the Ovary (00:02:30)</title>
    <itunes:summary><![CDATA[Key Feature Summary of Yolk Sac Tumor Second most common malignant germ cell tumorElevated serum alpha-fetoprotein (AFP)Friable, hemorrhagic, solid and cystic massReticular or microcystic pattern is most commonSchiller-Duval bodies are pathognomonic but variableIHC: positive for SALL4 and glypican-3; negative for CD30Main differential diagnosis: clear cell carcinoma and embryonal carcinomaDisclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only....]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary of Yolk Sac Tumor</b></p><ol><li>Second most common malignant germ cell tumor</li><li>Elevated serum alpha-fetoprotein (AFP)</li><li>Friable, hemorrhagic, solid and cystic mass</li><li>Reticular or microcystic pattern is most common</li><li>Schiller-Duval bodies are pathognomonic but variable</li><li>IHC: positive for SALL4 and glypican-3; negative for CD30</li><li>Main differential diagnosis: clear cell carcinoma and embryonal carcinoma</li></ol><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary of Yolk Sac Tumor</b></p><ol><li>Second most common malignant germ cell tumor</li><li>Elevated serum alpha-fetoprotein (AFP)</li><li>Friable, hemorrhagic, solid and cystic mass</li><li>Reticular or microcystic pattern is most common</li><li>Schiller-Duval bodies are pathognomonic but variable</li><li>IHC: positive for SALL4 and glypican-3; negative for CD30</li><li>Main differential diagnosis: clear cell carcinoma and embryonal carcinoma</li></ol><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18589781-synopsis-yolk-sac-tumor-of-the-ovary-00-02-30.mp3" length="1831329" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18589781</guid>
    <pubDate>Thu, 29 Jan 2026 06:00:00 -0500</pubDate>
    <itunes:duration>150</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, ovary, synopsis, Gyn. </itunes:keywords>
    <itunes:season>2026</itunes:season>
    <itunes:episode>13</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Sclerosing Bile Duct Diseases (00:13:19)</itunes:title>
    <title>Mini-Review: Sclerosing Bile Duct Diseases (00:13:19)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18454004-mini-review-sclerosing-bile-duct-diseases-00-13-19.mp3" length="9856155" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18454004</guid>
    <pubDate>Mon, 05 Jan 2026 06:00:00 -0500</pubDate>
    <itunes:duration>819</itunes:duration>
    <itunes:keywords>pathology, gallbladder, biliary inflammation, bile ducts, cholangitis</itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Gallbladder Tumors (00:16:31)</itunes:title>
    <title>Mini-Review: Gallbladder Tumors (00:16:31)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18452645-mini-review-gallbladder-tumors-00-16-31.mp3" length="11927853" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18452645</guid>
    <pubDate>Sun, 04 Jan 2026 21:00:00 -0500</pubDate>
    <itunes:duration>991</itunes:duration>
    <itunes:keywords>gallbladder, tumors, carcinomas, neoplasia, pathology</itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Gallbladder - The Duct of Luschka (00:14:57)</itunes:title>
    <title>Mini-Review: Gallbladder - The Duct of Luschka (00:14:57)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18452469-mini-review-gallbladder-the-duct-of-luschka-00-14-57.mp3" length="10796572" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18452469</guid>
    <pubDate>Sun, 04 Jan 2026 21:00:00 -0500</pubDate>
    <itunes:duration>897</itunes:duration>
    <itunes:keywords>gallbladder, inflammation, tumors, carcinomas, neoplasia</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Cholecystitis and Inflammation of the Biliary Tree (00:17:17)</itunes:title>
    <title>Mini-Review: Cholecystitis and Inflammation of the Biliary Tree (00:17:17)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18452448-mini-review-cholecystitis-and-inflammation-of-the-biliary-tree-00-17-17.mp3" length="12473353" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18452448</guid>
    <pubDate>Sun, 04 Jan 2026 21:00:00 -0500</pubDate>
    <itunes:duration>1037</itunes:duration>
    <itunes:keywords>gallbladder, inflammation, cholecystitis, biliary tree</itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Parasitic Infection of the Gallbladder and Biliary Tree (00:14:03)</itunes:title>
    <title>Mini-Review: Parasitic Infection of the Gallbladder and Biliary Tree (00:14:03)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18452417-mini-review-parasitic-infection-of-the-gallbladder-and-biliary-tree-00-14-03.mp3" length="10147421" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18452417</guid>
    <pubDate>Sun, 04 Jan 2026 20:00:00 -0500</pubDate>
    <itunes:duration>843</itunes:duration>
    <itunes:keywords>gallbladder, infection, biliary system, </itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Rare Endometrial Malignant Tumors (00:16:16)</itunes:title>
    <title>Mini-Review: Rare Endometrial Malignant Tumors (00:16:16)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18419533-mini-review-rare-endometrial-malignant-tumors-00-16-16.mp3" length="11748894" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18419533</guid>
    <pubDate>Sat, 27 Dec 2025 16:00:00 -0500</pubDate>
    <itunes:duration>976</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, uterus, endometrium, mini-review, Gyn. </itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>5</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Mesenchymal Tumors of the Uterine Corpus (00:21:13)</itunes:title>
    <title>Mini-Review: Mesenchymal Tumors of the Uterine Corpus (00:21:13)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18419502-mini-review-mesenchymal-tumors-of-the-uterine-corpus-00-21-13.mp3" length="15309920" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18419502</guid>
    <pubDate>Sat, 27 Dec 2025 16:00:00 -0500</pubDate>
    <itunes:duration>1273</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, uterus, sarcomas, molecular diagnosis, mini-review, Gyn. </itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>4</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: High-grade Tumors of the Endometrium (00:15:43)</itunes:title>
    <title>Mini-Review: High-grade Tumors of the Endometrium (00:15:43)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18419478-mini-review-high-grade-tumors-of-the-endometrium-00-15-43.mp3" length="11352361" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18419478</guid>
    <pubDate>Sat, 27 Dec 2025 15:00:00 -0500</pubDate>
    <itunes:duration>943</itunes:duration>
    <itunes:keywords>Pathology, neoplasm, uterus, endometrium, mini-review, Gyn. </itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>2</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Non-neoplastic Lesions of the Endometrium (00:15:29)</itunes:title>
    <title>Mini-Review: Non-neoplastic Lesions of the Endometrium (00:15:29)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18419418-mini-review-non-neoplastic-lesions-of-the-endometrium-00-15-29.mp3" length="11179334" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18419418</guid>
    <pubDate>Sat, 27 Dec 2025 15:00:00 -0500</pubDate>
    <itunes:duration>929</itunes:duration>
    <itunes:keywords>pathology, inflammatory, uterus, non-neoplastic</itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Common Tumors of Uterine Corpus-01 (0:19:23)</itunes:title>
    <title>Mini-Review: Common Tumors of Uterine Corpus-01 (0:19:23)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18276377-mini-review-common-tumors-of-uterine-corpus-01-0-19-23.mp3" length="13838794" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18276377</guid>
    <pubDate>Sat, 27 Dec 2025 15:00:00 -0500</pubDate>
    <itunes:duration>1151</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Uncommon Uterine Malignant Tumors (00:15:56)</itunes:title>
    <title>Mini-Review: Uncommon Uterine Malignant Tumors (00:15:56)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18419076-mini-review-uncommon-uterine-malignant-tumors-00-15-56.mp3" length="11503134" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18419076</guid>
    <pubDate>Sat, 27 Dec 2025 13:00:00 -0500</pubDate>
    <itunes:duration>956</itunes:duration>
    <itunes:keywords>pathology, neoplasm, uterus, neoplasm, mini-review, Gyn. </itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Endometrial Mesonephric-like Adenocarcinoma (0:14:31)</itunes:title>
    <title>Mini-Review: Endometrial Mesonephric-like Adenocarcinoma (0:14:31)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18419060-mini-review-endometrial-mesonephric-like-adenocarcinoma-0-14-31.mp3" length="10479674" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18419060</guid>
    <pubDate>Sat, 27 Dec 2025 13:00:00 -0500</pubDate>
    <itunes:duration>871</itunes:duration>
    <itunes:keywords>uterus, pathology, neoplasm, adenocarcinoma, malignant</itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Cutaneous Melanocytic Tumor with CRTC1-TRIM11 Fusion (CMTCT) (0:03:51)</itunes:title>
    <title>Synopsis: Cutaneous Melanocytic Tumor with CRTC1-TRIM11 Fusion (CMTCT) (0:03:51)</title>
    <itunes:summary><![CDATA[Feature Summary of CMTCT -- A novel pathologic entity of melanocytic origin, -- Variable positive immunostains for S100-protein, HMB45, and Melan-A. -- Diffusely positive stains for SOX10, MITF, and TRIM11 -- CRTC1 &amp; TRIM11 fusion is a signature genetic alteration. -- Seems to be a low-grade indolent tumor with malignant potential. ===== Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their ...]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of CMTCT</b><br/>-- A novel pathologic entity of melanocytic origin,<br/>-- Variable positive immunostains for S100-protein, HMB45, and Melan-A.<br/>-- Diffusely positive stains for SOX10, MITF, and TRIM11<br/>-- CRTC1 &amp; TRIM11 fusion is a signature genetic alteration.<br/>-- Seems to be a low-grade indolent tumor with malignant potential.</p><p>=====</p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of CMTCT</b><br/>-- A novel pathologic entity of melanocytic origin,<br/>-- Variable positive immunostains for S100-protein, HMB45, and Melan-A.<br/>-- Diffusely positive stains for SOX10, MITF, and TRIM11<br/>-- CRTC1 &amp; TRIM11 fusion is a signature genetic alteration.<br/>-- Seems to be a low-grade indolent tumor with malignant potential.</p><p>=====</p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18077337-synopsis-cutaneous-melanocytic-tumor-with-crtc1-trim11-fusion-cmtct-0-03-51.mp3" length="2806912" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18077337</guid>
    <pubDate>Sun, 26 Oct 2025 16:00:00 -0400</pubDate>
    <itunes:duration>231</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Gli-1-Altered Tumors, an emerging diagnostic entity (Gli-1) (0:30:51)</itunes:title>
    <title>Synopsis: Gli-1-Altered Tumors, an emerging diagnostic entity (Gli-1) (0:30:51)</title>
    <itunes:summary><![CDATA[Feature Summary of Gli-1-altered Tumors   1.  A distinct group of mesenchymal neoplasms with low malignant behavior.   2.  Found in a wide variety of organ sites.  3.  Multinodular or plexiform growth patterns, and monomorphic round to spindle epithelioid tumor cells.   4.  Positive for CD56 and S100, but highly variable immunohistochemical stain profile.  5.  Gli-1 gene fusion involving ACTB, MALAT1, and PTCHI gene partners is characteristic....]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of Gli-1-altered Tumors</b>  <br/>1.  A distinct group of mesenchymal neoplasms with low malignant behavior.  <br/>2.  Found in a wide variety of organ sites. <br/>3.  Multinodular or plexiform growth patterns, and monomorphic round to spindle epithelioid tumor cells.  <br/>4.  Positive for CD56 and S100, but highly variable immunohistochemical stain profile. <br/>5.  Gli-1 gene fusion involving ACTB, MALAT1, and PTCHI gene partners is characteristic. <br/>6.  Gli-1 gene amplification accompanied by co-amplification of other genes mapped to the chromosome 12q13 to q15 region.  <br/>7.  Main differential diagnosis include solitary fibrous tumor, glomus tumor, clear cell sarcoma, and follicular dendritic cell sarcoma.</p><p>=====</p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of Gli-1-altered Tumors</b>  <br/>1.  A distinct group of mesenchymal neoplasms with low malignant behavior.  <br/>2.  Found in a wide variety of organ sites. <br/>3.  Multinodular or plexiform growth patterns, and monomorphic round to spindle epithelioid tumor cells.  <br/>4.  Positive for CD56 and S100, but highly variable immunohistochemical stain profile. <br/>5.  Gli-1 gene fusion involving ACTB, MALAT1, and PTCHI gene partners is characteristic. <br/>6.  Gli-1 gene amplification accompanied by co-amplification of other genes mapped to the chromosome 12q13 to q15 region.  <br/>7.  Main differential diagnosis include solitary fibrous tumor, glomus tumor, clear cell sarcoma, and follicular dendritic cell sarcoma.</p><p>=====</p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18077279-synopsis-gli-1-altered-tumors-an-emerging-diagnostic-entity-gli-1-0-30-51.mp3" length="4156707" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18077279</guid>
    <pubDate>Sun, 26 Oct 2025 16:00:00 -0400</pubDate>
    <itunes:duration>344</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Superficial CD34-positive Fibroblastic Tumor (SCD34FT) (0:02:30)</itunes:title>
    <title>Synopsis: Superficial CD34-positive Fibroblastic Tumor (SCD34FT) (0:02:30)</title>
    <itunes:summary><![CDATA[Feature summary of SCD34FT - Soft tissue tumor of borderline malignancy.  - Tends to occur in the lower extremities in adults.  - Solid spindle cell in fascicular and storiform pattern.  - Apparent nuclear pleo-morphism and hyperchromatism.  and, - Strongly positive for CD34 and CADM3, by immunohisto-chemistry.  ===== Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their...]]></itunes:summary>
    <description><![CDATA[<p><b>Feature summary of SCD34FT</b><br/>- Soft tissue tumor of borderline malignancy. <br/>- Tends to occur in the lower extremities in adults. <br/>- Solid spindle cell in fascicular and storiform pattern. <br/>- Apparent nuclear pleo-morphism and hyperchromatism.  and,<br/>- Strongly positive for CD34 and CADM3, by immunohisto-chemistry. </p><p>=====</p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature summary of SCD34FT</b><br/>- Soft tissue tumor of borderline malignancy. <br/>- Tends to occur in the lower extremities in adults. <br/>- Solid spindle cell in fascicular and storiform pattern. <br/>- Apparent nuclear pleo-morphism and hyperchromatism.  and,<br/>- Strongly positive for CD34 and CADM3, by immunohisto-chemistry. </p><p>=====</p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18077255-synopsis-superficial-cd34-positive-fibroblastic-tumor-scd34ft-0-02-30.mp3" length="1832322" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18077255</guid>
    <pubDate>Sun, 26 Oct 2025 16:00:00 -0400</pubDate>
    <itunes:duration>150</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Molecular Markers &amp; Pathology Diagnosis (part-3) (0:17:50)</itunes:title>
    <title>Mini-Review: Molecular Markers &amp; Pathology Diagnosis (part-3) (0:17:50)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18076098-mini-review-molecular-markers-pathology-diagnosis-part-3-0-17-50.mp3" length="12876785" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18076098</guid>
    <pubDate>Sun, 26 Oct 2025 12:00:00 -0400</pubDate>
    <itunes:duration>1070</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Molecular Markers &amp; Pathology Diagnosis (part-2) (0:16:44)</itunes:title>
    <title>Mini-Review: Molecular Markers &amp; Pathology Diagnosis (part-2) (0:16:44)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18076078-mini-review-molecular-markers-pathology-diagnosis-part-2-0-16-44.mp3" length="12076811" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18076078</guid>
    <pubDate>Sun, 26 Oct 2025 12:00:00 -0400</pubDate>
    <itunes:duration>1004</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review:  Molecular Markers &amp; Pathology Diagnosis (part-1) (0:17:47)</itunes:title>
    <title>Mini-Review:  Molecular Markers &amp; Pathology Diagnosis (part-1) (0:17:47)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/18076050-mini-review-molecular-markers-pathology-diagnosis-part-1-0-17-47.mp3" length="12838543" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18076050</guid>
    <pubDate>Sun, 26 Oct 2025 12:00:00 -0400</pubDate>
    <itunes:duration>1067</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Premalignant Lesions of the Gallbladder (0:16:08)</itunes:title>
    <title>Mini-Review: Premalignant Lesions of the Gallbladder (0:16:08)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17986884-mini-review-premalignant-lesions-of-the-gallbladder-0-16-08.mp3" length="11646086" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17986884</guid>
    <pubDate>Thu, 09 Oct 2025 21:00:00 -0400</pubDate>
    <itunes:duration>968</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Common Mimics of Gallbladder Carcinoma (0:17:10)</itunes:title>
    <title>Mini-Review: Common Mimics of Gallbladder Carcinoma (0:17:10)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17986870-mini-review-common-mimics-of-gallbladder-carcinoma-0-17-10.mp3" length="12388379" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17986870</guid>
    <pubDate>Thu, 09 Oct 2025 21:00:00 -0400</pubDate>
    <itunes:duration>1030</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Small Intestine) Sample Study Questions (0:22:26)</itunes:title>
    <title>(AIQz500 Pathology of the Small Intestine) Sample Study Questions (0:22:26)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17840222-aiqz500-pathology-of-the-small-intestine-sample-study-questions-0-22-26.mp3" length="16186087" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17840222</guid>
    <pubDate>Sun, 14 Sep 2025 08:00:00 -0400</pubDate>
    <itunes:duration>1346</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Drug-induced Injury in the Duodenum (0:18:07)</itunes:title>
    <title>Mini-Review: Drug-induced Injury in the Duodenum (0:18:07)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17794662-mini-review-drug-induced-injury-in-the-duodenum-0-18-07.mp3" length="13074242" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17794662</guid>
    <pubDate>Fri, 05 Sep 2025 08:00:00 -0400</pubDate>
    <itunes:duration>1087</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Celiac Disease / Gluten-sensitive Enteropathy (0:18:58)</itunes:title>
    <title>Mini-Review: Celiac Disease / Gluten-sensitive Enteropathy (0:18:58)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17794635-mini-review-celiac-disease-gluten-sensitive-enteropathy-0-18-58.mp3" length="13686781" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17794635</guid>
    <pubDate>Fri, 05 Sep 2025 08:00:00 -0400</pubDate>
    <itunes:duration>1138</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Immune Checkpoint Inhibitors &amp; Enteritis (0:17:26)</itunes:title>
    <title>Mini-Review: Immune Checkpoint Inhibitors &amp; Enteritis (0:17:26)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17793026-mini-review-immune-checkpoint-inhibitors-enteritis-0-17-26.mp3" length="12585867" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17793026</guid>
    <pubDate>Thu, 04 Sep 2025 21:00:00 -0400</pubDate>
    <itunes:duration>1046</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Common Tumors of the Small Intestine (0:13:47)</itunes:title>
    <title>Mini-Review: Common Tumors of the Small Intestine (0:13:47)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17765157-mini-review-common-tumors-of-the-small-intestine-0-13-47.mp3" length="9957732" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17765157</guid>
    <pubDate>Sun, 31 Aug 2025 22:00:00 -0400</pubDate>
    <itunes:duration>827</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Review: Polyps of the Duodenum (0:21:02)</itunes:title>
    <title>Review: Polyps of the Duodenum (0:21:02)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17765146-review-polyps-of-the-duodenum-0-21-02.mp3" length="15180721" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17765146</guid>
    <pubDate>Sun, 31 Aug 2025 22:00:00 -0400</pubDate>
    <itunes:duration>1262</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Enigmatic Conditions in Spleen Pathology (0:17:24)</itunes:title>
    <title>Mini-Review: Enigmatic Conditions in Spleen Pathology (0:17:24)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17715881-mini-review-enigmatic-conditions-in-spleen-pathology-0-17-24.mp3" length="12561416" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17715881</guid>
    <pubDate>Fri, 22 Aug 2025 08:00:00 -0400</pubDate>
    <itunes:duration>1044</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Splenic Marginal Zone Lymphoma (0:21:15)</itunes:title>
    <title>Mini-Review: Splenic Marginal Zone Lymphoma (0:21:15)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17715867-mini-review-splenic-marginal-zone-lymphoma-0-21-15.mp3" length="15332445" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17715867</guid>
    <pubDate>Fri, 22 Aug 2025 08:00:00 -0400</pubDate>
    <itunes:duration>1275</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Splenic B-cell Lymphomas (0:22:42)</itunes:title>
    <title>Mini-Review: Splenic B-cell Lymphomas (0:22:42)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17715854-mini-review-splenic-b-cell-lymphomas-0-22-42.mp3" length="16372232" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17715854</guid>
    <pubDate>Fri, 22 Aug 2025 08:00:00 -0400</pubDate>
    <itunes:duration>1362</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Spleen, an unsung hero (0:37:07)</itunes:title>
    <title>Mini-Review: Spleen, an unsung hero (0:37:07)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17715765-mini-review-spleen-an-unsung-hero-0-37-07.mp3" length="26674086" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17715765</guid>
    <pubDate>Fri, 22 Aug 2025 08:00:00 -0400</pubDate>
    <itunes:duration>2220</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Drugs and Colitis (0:06:25)</itunes:title>
    <title>Synopsis: Drugs and Colitis (0:06:25)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17665363-synopsis-drugs-and-colitis-0-06-25.mp3" length="4646266" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17665363</guid>
    <pubDate>Wed, 13 Aug 2025 10:00:00 -0400</pubDate>
    <itunes:duration>385</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Immune Checkpoint Inhibitors (ICPI s) &amp; Colitis (0:05:04)</itunes:title>
    <title>Mini-Review: Immune Checkpoint Inhibitors (ICPI s) &amp; Colitis (0:05:04)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.   ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><br/></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17665313-mini-review-immune-checkpoint-inhibitors-icpi-s-colitis-0-05-04.mp3" length="3683666" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17665313</guid>
    <pubDate>Wed, 13 Aug 2025 10:00:00 -0400</pubDate>
    <itunes:duration>304</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Review: Polyps of the Colon, from the Mundane to the Exotic (0:31:28)</itunes:title>
    <title>Review: Polyps of the Colon, from the Mundane to the Exotic (0:31:28)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17665234-review-polyps-of-the-colon-from-the-mundane-to-the-exotic-0-31-28.mp3" length="22692759" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17665234</guid>
    <pubDate>Wed, 13 Aug 2025 10:00:00 -0400</pubDate>
    <itunes:duration>1888</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis:  Adenoma-Like Colorectal Adenocarcinoma (0:03:03)</itunes:title>
    <title>Synopsis:  Adenoma-Like Colorectal Adenocarcinoma (0:03:03)</title>
    <itunes:summary><![CDATA[Feature Summary 84% are low grades.73% with low tumor budding.71% pure, (the remainder are mixed).63% in the right colon; 22% in the sigmoid.45% with more intraepithelial lymphocytes.36% with K-Ras and B-Raf V-600E, mutation.20% with nodal metastasis.Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By acce...]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary</b></p><ul><li>84% are low grades.</li><li>73% with low tumor budding.</li><li>71% pure, (the remainder are mixed).</li><li>63% in the right colon; 22% in the sigmoid.</li><li>45% with more intraepithelial lymphocytes.</li><li>36% with K-Ras and B-Raf V-600E, mutation.</li><li>20% with nodal metastasis.</li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary</b></p><ul><li>84% are low grades.</li><li>73% with low tumor budding.</li><li>71% pure, (the remainder are mixed).</li><li>63% in the right colon; 22% in the sigmoid.</li><li>45% with more intraepithelial lymphocytes.</li><li>36% with K-Ras and B-Raf V-600E, mutation.</li><li>20% with nodal metastasis.</li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17665117-synopsis-adenoma-like-colorectal-adenocarcinoma-0-03-03.mp3" length="2222563" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17665117</guid>
    <pubDate>Wed, 13 Aug 2025 10:00:00 -0400</pubDate>
    <itunes:duration>183</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Pleura) Sample Study Questions (0:20:46)</itunes:title>
    <title>(AIQz500 Pathology of the Pleura) Sample Study Questions (0:20:46)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17602645-aiqz500-pathology-of-the-pleura-sample-study-questions-0-20-46.mp3" length="14981093" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17602645</guid>
    <pubDate>Fri, 01 Aug 2025 21:00:00 -0400</pubDate>
    <itunes:duration>1246</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Features of Specific Types of Thymoma (0:19:19)</itunes:title>
    <title>Mini-Review: Features of Specific Types of Thymoma (0:19:19)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17554717-mini-review-features-of-specific-types-of-thymoma-0-19-19.mp3" length="13941929" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17554717</guid>
    <pubDate>Wed, 23 Jul 2025 20:00:00 -0400</pubDate>
    <itunes:duration>1159</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Mediastinum) Sample Study Questions (0:20:24)</itunes:title>
    <title>(AIQz500 Pathology of the Mediastinum) Sample Study Questions (0:20:24)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17554707-aiqz500-pathology-of-the-mediastinum-sample-study-questions-0-20-24.mp3" length="14719669" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17554707</guid>
    <pubDate>Wed, 23 Jul 2025 20:00:00 -0400</pubDate>
    <itunes:duration>1224</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Classification of Thymomas (0:12:03)</itunes:title>
    <title>Mini-Review: Classification of Thymomas (0:12:03)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17554684-mini-review-classification-of-thymomas-0-12-03.mp3" length="8710103" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17554684</guid>
    <pubDate>Wed, 23 Jul 2025 20:00:00 -0400</pubDate>
    <itunes:duration>723</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Mediastinal Tumors (0:22:403)</itunes:title>
    <title>Mini-Review: Mediastinal Tumors (0:22:403)</title>
    <itunes:summary><![CDATA[Suggested References https://pubmed.ncbi.nlm.nih.gov/34564969/  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024054/  https://pubmed.ncbi.nlm.nih.gov/35227908/ https://pubmed.ncbi.nlm.nih.gov/26295375/ Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to ...]]></itunes:summary>
    <description><![CDATA[<p><b>Suggested References</b><br/>https://pubmed.ncbi.nlm.nih.gov/34564969/ <br/>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024054/ <br/>https://pubmed.ncbi.nlm.nih.gov/35227908/<br/>https://pubmed.ncbi.nlm.nih.gov/26295375/</p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Suggested References</b><br/>https://pubmed.ncbi.nlm.nih.gov/34564969/ <br/>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024054/ <br/>https://pubmed.ncbi.nlm.nih.gov/35227908/<br/>https://pubmed.ncbi.nlm.nih.gov/26295375/</p><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17554618-mini-review-mediastinal-tumors-0-22-403.mp3" length="15439155" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17554618</guid>
    <pubDate>Wed, 23 Jul 2025 20:00:00 -0400</pubDate>
    <itunes:duration>1323</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Thymic Carcinomas (0:03:45)</itunes:title>
    <title>Mini-Review: Thymic Carcinomas (0:03:45)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17357694-mini-review-thymic-carcinomas-0-03-45.mp3" length="2725955" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17357694</guid>
    <pubDate>Wed, 18 Jun 2025 07:00:00 -0400</pubDate>
    <itunes:duration>225</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Thymomas, part-B (0:05:20)</itunes:title>
    <title>Mini-Review: Thymomas, part-B (0:05:20)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17357686-mini-review-thymomas-part-b-0-05-20.mp3" length="3866981" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17357686</guid>
    <pubDate>Wed, 18 Jun 2025 07:00:00 -0400</pubDate>
    <itunes:duration>320</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>2</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Thymomas, part-A (0:05:14)</itunes:title>
    <title>Mini-Review: Thymomas, part-A (0:05:14)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17357673-mini-review-thymomas-part-a-0-05-14.mp3" length="3797705" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17357673</guid>
    <pubDate>Wed, 18 Jun 2025 07:00:00 -0400</pubDate>
    <itunes:duration>314</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:season>2025</itunes:season>
    <itunes:episode>1</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Stomach) Sample Study Questions (0:19:18)</itunes:title>
    <title>(AIQz500 Pathology of the Stomach) Sample Study Questions (0:19:18)</title>
    <itunes:summary><![CDATA[This audio is complimentary material to study book "AIQz500 For Pathology of the Stomach" (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LL...]]></itunes:summary>
    <description><![CDATA[<p>This audio is complimentary material to study book &quot;AIQz500 For Pathology of the Stomach&quot; (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio is complimentary material to study book &quot;AIQz500 For Pathology of the Stomach&quot; (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17259809-aiqz500-pathology-of-the-stomach-sample-study-questions-0-19-18.mp3" length="13927524" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17259809</guid>
    <pubDate>Sat, 31 May 2025 23:00:00 -0400</pubDate>
    <itunes:duration>1158</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Stomach) Sample Study Questions (0:19:31)</itunes:title>
    <title>(AIQz500 Pathology of the Stomach) Sample Study Questions (0:19:31)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 For Pathology of the Stomach" (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, ...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 For Pathology of the Stomach&quot; (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 For Pathology of the Stomach&quot; (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17259719-aiqz500-pathology-of-the-stomach-sample-study-questions-0-19-31.mp3" length="14084259" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17259719</guid>
    <pubDate>Sat, 31 May 2025 22:00:00 -0400</pubDate>
    <itunes:duration>1171</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Esophagitis dissecans superficialis (EDS) (0:08:47)</itunes:title>
    <title>Mini-Review: Esophagitis dissecans superficialis (EDS) (0:08:47)</title>
    <itunes:summary><![CDATA[Summary Asymptomatic or present with dysphagia, odynophagia, or regurgitationLongitudinal sloughing with intact underlying mucosa on endoscopySuperficial epithelial necrosis with intraepithelial splittingTwo-toned squamous epithelium: necrotic surface over viable basal layerMinimal inflammatory response despite extensive sloughingDisclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the i...]]></itunes:summary>
    <description><![CDATA[<p><b>Summary</b></p><ul><li>Asymptomatic or present with dysphagia, odynophagia, or regurgitation</li><li>Longitudinal sloughing with intact underlying mucosa on endoscopy</li><li>Superficial epithelial necrosis with intraepithelial splitting</li><li>Two-toned squamous epithelium: necrotic surface over viable basal layer</li><li>Minimal inflammatory response despite extensive sloughing</li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Summary</b></p><ul><li>Asymptomatic or present with dysphagia, odynophagia, or regurgitation</li><li>Longitudinal sloughing with intact underlying mucosa on endoscopy</li><li>Superficial epithelial necrosis with intraepithelial splitting</li><li>Two-toned squamous epithelium: necrotic surface over viable basal layer</li><li>Minimal inflammatory response despite extensive sloughing</li></ul><p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17239363-mini-review-esophagitis-dissecans-superficialis-eds-0-08-47.mp3" length="5964023" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17239363</guid>
    <pubDate>Wed, 28 May 2025 06:00:00 -0400</pubDate>
    <itunes:duration>527</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Esophagus) Sample Study Questions (0:21:42)</itunes:title>
    <title>(AIQz500 Pathology of the Esophagus) Sample Study Questions (0:21:42)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 For Pathology of the Esophagus" (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 For Pathology of the Esophagus&quot; (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 For Pathology of the Esophagus&quot; (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17239334-aiqz500-pathology-of-the-esophagus-sample-study-questions-0-21-42.mp3" length="15659760" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17239334</guid>
    <pubDate>Wed, 28 May 2025 06:00:00 -0400</pubDate>
    <itunes:duration>1302</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Review: Non-mesothelial Spindle  Cell Tumors of Pleura (0:25:21)</itunes:title>
    <title>Review: Non-mesothelial Spindle  Cell Tumors of Pleura (0:25:21)</title>
    <itunes:summary><![CDATA[Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17071749-review-non-mesothelial-spindle-cell-tumors-of-pleura-0-25-21.mp3" length="17512439" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17071749</guid>
    <pubDate>Wed, 30 Apr 2025 09:00:00 -0400</pubDate>
    <itunes:duration>1521</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Esophagitis dissecans superficialis (EDS) (0:08:47)</itunes:title>
    <title>Mini-Review: Esophagitis dissecans superficialis (EDS) (0:08:47)</title>
    <itunes:summary><![CDATA[Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/17071737-mini-review-esophagitis-dissecans-superficialis-eds-0-08-47.mp3" length="5943071" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17071737</guid>
    <pubDate>Wed, 30 Apr 2025 08:00:00 -0400</pubDate>
    <itunes:duration>527</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Review: Update on Diagnosis of Mesothelioma (0:17:13)</itunes:title>
    <title>Review: Update on Diagnosis of Mesothelioma (0:17:13)</title>
    <itunes:summary><![CDATA[Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16972413-review-update-on-diagnosis-of-mesothelioma-0-17-13.mp3" length="11806585" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16972413</guid>
    <pubDate>Sun, 13 Apr 2025 21:00:00 -0400</pubDate>
    <itunes:duration>1033</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Review: 2023 Guidelines for Mesothelioma Diagnosis (0:59:21)</itunes:title>
    <title>Review: 2023 Guidelines for Mesothelioma Diagnosis (0:59:21)</title>
    <itunes:summary><![CDATA[Husain AN, Chapel DB, Attanoos R, et al. (2024). Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med. 148(11):1251-1271. doi:10.5858/arpa.2023-0304-RA   Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it a...]]></itunes:summary>
    <description><![CDATA[<p>Husain AN, Chapel DB, Attanoos R, et al. (2024). Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med. 148(11):1251-1271. doi:10.5858/arpa.2023-0304-RA  </p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>Husain AN, Chapel DB, Attanoos R, et al. (2024). Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med. 148(11):1251-1271. doi:10.5858/arpa.2023-0304-RA  </p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16972346-review-2023-guidelines-for-mesothelioma-diagnosis-0-59-21.mp3" length="40420599" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16972346</guid>
    <pubDate>Sun, 13 Apr 2025 21:00:00 -0400</pubDate>
    <itunes:duration>3561</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Gastric Mesenchymal Tumors, Molecular Diagnosis (0:11:44)</itunes:title>
    <title>Mini-Review: Gastric Mesenchymal Tumors, Molecular Diagnosis (0:11:44)</title>
    <itunes:summary><![CDATA[The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16881624-mini-review-gastric-mesenchymal-tumors-molecular-diagnosis-0-11-44.mp3" length="7852787" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16881624</guid>
    <pubDate>Sat, 29 Mar 2025 18:00:00 -0400</pubDate>
    <itunes:duration>704</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Gastric Mesenchymal Tumors, Morphological Features (0:21:55)</itunes:title>
    <title>Mini-Review: Gastric Mesenchymal Tumors, Morphological Features (0:21:55)</title>
    <itunes:summary><![CDATA[The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16881615-mini-review-gastric-mesenchymal-tumors-morphological-features-0-21-55.mp3" length="14714585" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16881615</guid>
    <pubDate>Sat, 29 Mar 2025 18:00:00 -0400</pubDate>
    <itunes:duration>1315</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Molecular Classification of Gastric Adenocarcinomas (0:02:28)</itunes:title>
    <title>Mini-Review: Molecular Classification of Gastric Adenocarcinomas (0:02:28)</title>
    <itunes:summary><![CDATA[The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16881575-mini-review-molecular-classification-of-gastric-adenocarcinomas-0-02-28.mp3" length="1811008" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16881575</guid>
    <pubDate>Sat, 29 Mar 2025 18:00:00 -0400</pubDate>
    <itunes:duration>148</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Introducing AIQz500 Book Series</itunes:title>
    <title>Introducing AIQz500 Book Series</title>
    <itunes:summary><![CDATA[AIQz500 Book Series, presents 500 well formulated study questions in each volume designed to emulate the rigor of real-world diagnostic scenarios in  pathology, helping sharpen skills essential for exam success and clinical readiness. AIQz500 turns study into effortless mastery, guiding readers toward comprehensive, exam-ready expertise and diagnostic confidence in diagnostic pathology. ]]></itunes:summary>
    <description><![CDATA[<p>AIQz500 Book Series, presents 500 well formulated study questions in each volume designed to emulate the rigor of real-world diagnostic scenarios in  pathology, helping sharpen skills essential for exam success and clinical readiness. AIQz500 turns study into effortless mastery, guiding readers toward comprehensive, exam-ready expertise and diagnostic confidence in diagnostic pathology.</p>]]></description>
    <content:encoded><![CDATA[<p>AIQz500 Book Series, presents 500 well formulated study questions in each volume designed to emulate the rigor of real-world diagnostic scenarios in  pathology, helping sharpen skills essential for exam success and clinical readiness. AIQz500 turns study into effortless mastery, guiding readers toward comprehensive, exam-ready expertise and diagnostic confidence in diagnostic pathology.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16839596-introducing-aiqz500-book-series.mp3" length="9220013" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16839596</guid>
    <pubDate>Sat, 22 Mar 2025 10:00:00 -0400</pubDate>
    <itunes:duration>801</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Liver) Sample Study Questions (0:24:40)</itunes:title>
    <title>(AIQz500 Pathology of the Liver) Sample Study Questions (0:24:40)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 For Pathology of the Liver" (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NN...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 For Pathology of the Liver&quot; (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 For Pathology of the Liver&quot; (2025). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16509524-aiqz500-pathology-of-the-liver-sample-study-questions-0-24-40.mp3" length="17791030" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16509524</guid>
    <pubDate>Mon, 27 Jan 2025 06:00:00 -0500</pubDate>
    <itunes:duration>1480</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Urinary Bladder) Sample Study Questions (0:21:15)</itunes:title>
    <title>(AIQz500 Pathology of the Urinary Bladder) Sample Study Questions (0:21:15)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 For Pathology of the Urinary Bladder" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPat...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 For Pathology of the Urinary Bladder&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 For Pathology of the Urinary Bladder&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16382561-aiqz500-pathology-of-the-urinary-bladder-sample-study-questions-0-21-15.mp3" length="15334391" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16382561</guid>
    <pubDate>Sat, 04 Jan 2025 21:00:00 -0500</pubDate>
    <itunes:duration>1275</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Appendix) Sample Study Questions. part 02 (0:10:11)</itunes:title>
    <title>(AIQz500 Pathology of the Appendix) Sample Study Questions. part 02 (0:10:11)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 Pathology of the Appendix" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNM...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Appendix&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Appendix&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16365019-aiqz500-pathology-of-the-appendix-sample-study-questions-part-02-0-10-11.mp3" length="5513075" type="audio/mpeg" />
    <link>http://www.essentialpathology.info/AIQZ/LanA99en/LaAud10/8uzzLaA993n.html</link>
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16365019</guid>
    <pubDate>Tue, 31 Dec 2024 22:00:00 -0500</pubDate>
    <itunes:duration>611</itunes:duration>
    <itunes:keywords>pathology, diagnosis, test preparation, board exam, appendix</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Appendix) Sample Study Questions, Part 01 (0:10:52)</itunes:title>
    <title>(AIQz500 Pathology of the Appendix) Sample Study Questions, Part 01 (0:10:52)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 Pathology  of the Appendix" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPatholog...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology  of the Appendix&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology  of the Appendix&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16365008-aiqz500-pathology-of-the-appendix-sample-study-questions-part-01-0-10-52.mp3" length="5937227" type="audio/mpeg" />
    <link>http://www.essentialpathology.info/AIQZ/LanA99en/LaAud10/8uzzLaA993n.html</link>
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16365008</guid>
    <pubDate>Tue, 31 Dec 2024 22:00:00 -0500</pubDate>
    <itunes:duration>652</itunes:duration>
    <itunes:keywords>pathology, diagnosis, test preparation, board exam, appendix</itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Review: Urinary Bladder Carcinoma Variants, a narrative presentation (0:13:51)</itunes:title>
    <title>Review: Urinary Bladder Carcinoma Variants, a narrative presentation (0:13:51)</title>
    <itunes:summary><![CDATA[List of bladder Carcinoma variants presented in the review: Squamous Cell Bladder Carcinoma (SCC)Non-bilharzial-associated SCC (NB-SCC)Bladder adenocarcinomasPrimary bladder adenocarcinomaSecondary bladder adenocarcinomaIntestinal/enteric bladder adenocarcinomaClear cell adenocarcinomaSignet-ring cell adenocarcinomaUrachal adenocarcinomaMucinous urachal adenocarcinomaEnteric urachal adenocarcinomaSignet-ring cell urachal adenocarcinomaNon-urachal bladder adenocarcinomaHigh-grade neuroendocrin...]]></itunes:summary>
    <description><![CDATA[<p><b>List of bladder Carcinoma variants presented in the review:</b></p><ul><li><b>Squamous Cell Bladder Carcinoma (SCC)</b></li><li><b>Non-bilharzial-associated SCC (NB-SCC)</b></li><li><b>Bladder adenocarcinomas</b><ul><li>Primary bladder adenocarcinoma</li><li>Secondary bladder adenocarcinoma</li><li>Intestinal/enteric bladder adenocarcinoma</li><li>Clear cell adenocarcinoma</li><li>Signet-ring cell adenocarcinoma</li></ul></li><li><b>Urachal adenocarcinoma</b><ul><li>Mucinous urachal adenocarcinoma</li><li>Enteric urachal adenocarcinoma</li><li>Signet-ring cell urachal adenocarcinoma</li><li>Non-urachal bladder adenocarcinoma</li></ul></li><li><b>High-grade neuroendocrine carcinoma</b><ul><li>Pure small cell carcinoma (SmCC)</li><li>Mixed histology SmCC (with UC, adenocarcinoma, or SCC)</li></ul></li><li><b>Bladder sarcomas</b><ul><li>Leiomyosarcoma of the bladder</li><li>Rhabdomyosarcoma</li><li>Angiosarcomas</li></ul></li><li><b>Urothelial Carcinoma (UC) variants</b><ul><li>Urothelial with squamous differentiation</li><li>Urothelial with glandular differentiation</li><li>Plasmacytoid/signet ring and lymphoma-like</li><li>Undifferentiated</li><li>Lymphoepithelioma-like carcinomas</li><li>Clear cell variant</li><li>Lipid cell variant</li><li>Sarcomatoid or carcinosarcoma variants</li><li>Micropapillary Urothelial Carcinoma (mUC)</li><li>Nested Urothelial Carcinoma (nUC)</li><li>Carcinosarcoma (CS)</li></ul></li></ul><p>Content solely for training and education purposes.</p>]]></description>
    <content:encoded><![CDATA[<p><b>List of bladder Carcinoma variants presented in the review:</b></p><ul><li><b>Squamous Cell Bladder Carcinoma (SCC)</b></li><li><b>Non-bilharzial-associated SCC (NB-SCC)</b></li><li><b>Bladder adenocarcinomas</b><ul><li>Primary bladder adenocarcinoma</li><li>Secondary bladder adenocarcinoma</li><li>Intestinal/enteric bladder adenocarcinoma</li><li>Clear cell adenocarcinoma</li><li>Signet-ring cell adenocarcinoma</li></ul></li><li><b>Urachal adenocarcinoma</b><ul><li>Mucinous urachal adenocarcinoma</li><li>Enteric urachal adenocarcinoma</li><li>Signet-ring cell urachal adenocarcinoma</li><li>Non-urachal bladder adenocarcinoma</li></ul></li><li><b>High-grade neuroendocrine carcinoma</b><ul><li>Pure small cell carcinoma (SmCC)</li><li>Mixed histology SmCC (with UC, adenocarcinoma, or SCC)</li></ul></li><li><b>Bladder sarcomas</b><ul><li>Leiomyosarcoma of the bladder</li><li>Rhabdomyosarcoma</li><li>Angiosarcomas</li></ul></li><li><b>Urothelial Carcinoma (UC) variants</b><ul><li>Urothelial with squamous differentiation</li><li>Urothelial with glandular differentiation</li><li>Plasmacytoid/signet ring and lymphoma-like</li><li>Undifferentiated</li><li>Lymphoepithelioma-like carcinomas</li><li>Clear cell variant</li><li>Lipid cell variant</li><li>Sarcomatoid or carcinosarcoma variants</li><li>Micropapillary Urothelial Carcinoma (mUC)</li><li>Nested Urothelial Carcinoma (nUC)</li><li>Carcinosarcoma (CS)</li></ul></li></ul><p>Content solely for training and education purposes.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16256299-review-urinary-bladder-carcinoma-variants-a-narrative-presentation-0-13-51.mp3" length="10003223" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16256299</guid>
    <pubDate>Tue, 10 Dec 2024 15:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2173407/16256299/transcript" type="text/html" />
    <itunes:duration>831</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Review: Urinary Bladder Carcinoma Variants, a conversational discussion (0:28:00)</itunes:title>
    <title>Review: Urinary Bladder Carcinoma Variants, a conversational discussion (0:28:00)</title>
    <itunes:summary><![CDATA[List of bladder cancer variants discussed in the review: Squamous Cell Bladder Carcinoma (SCC)Non-bilharzial-associated SCC (NB-SCC)Bladder adenocarcinomasPrimary bladder adenocarcinomaSecondary bladder adenocarcinomaIntestinal/enteric bladder adenocarcinomaClear cell adenocarcinomaSignet-ring cell adenocarcinomaUrachal adenocarcinomaMucinous urachal adenocarcinomaEnteric urachal adenocarcinomaSignet-ring cell urachal adenocarcinomaNon-urachal bladder adenocarcinomaHigh-grade neuroendocrine c...]]></itunes:summary>
    <description><![CDATA[<p><b>List of bladder cancer variants discussed in the review:</b></p><ul><li><b>Squamous Cell Bladder Carcinoma (SCC)</b></li><li><b>Non-bilharzial-associated SCC (NB-SCC)</b></li><li><b>Bladder adenocarcinomas</b><ul><li>Primary bladder adenocarcinoma</li><li>Secondary bladder adenocarcinoma</li><li>Intestinal/enteric bladder adenocarcinoma</li><li>Clear cell adenocarcinoma</li><li>Signet-ring cell adenocarcinoma</li></ul></li><li><b>Urachal adenocarcinoma</b><ul><li>Mucinous urachal adenocarcinoma</li><li>Enteric urachal adenocarcinoma</li><li>Signet-ring cell urachal adenocarcinoma</li><li>Non-urachal bladder adenocarcinoma</li></ul></li><li><b>High-grade neuroendocrine carcinoma</b><ul><li>Pure small cell carcinoma (SmCC)</li><li>Mixed histology SmCC (with UC, adenocarcinoma, or SCC)</li></ul></li><li><b>Bladder sarcomas</b><ul><li>Leiomyosarcoma of the bladder</li><li>Rhabdomyosarcoma</li><li>Angiosarcomas</li></ul></li><li><b>Urothelial Carcinoma (UC) variants</b><ul><li>Urothelial with squamous differentiation</li><li>Urothelial with glandular differentiation</li><li>Nested variant</li><li>Microcystic variant</li><li>Micropapillary variant</li><li>Plasmacytoid/signet ring and lymphoma-like</li><li>Undifferentiated</li><li>Lymphoepithelioma-like</li><li>Clear cell variant</li><li>Lipid cell variant</li><li>Sarcomatoid or carcinosarcoma variants</li></ul></li><li><b>Plasmacytoid Urothelial Carcinoma (pUC)</b></li><li><b>Lymphoepithelioma-Like Carcinomas</b></li><li><b>Micropapillary Urothelial Carcinoma (mUC)</b></li><li><b>Nested Urothelial Carcinoma (nUC)</b></li><li><b>Nested Variant of Urothelial Carcinoma (NVUC)</b></li><li><b>Large Nested Urothelial Carcinoma (LNUC)</b></li><li><b>Carcinosarcoma (CS)</b></li></ul><p>Content solely for training and education purposes.</p>]]></description>
    <content:encoded><![CDATA[<p><b>List of bladder cancer variants discussed in the review:</b></p><ul><li><b>Squamous Cell Bladder Carcinoma (SCC)</b></li><li><b>Non-bilharzial-associated SCC (NB-SCC)</b></li><li><b>Bladder adenocarcinomas</b><ul><li>Primary bladder adenocarcinoma</li><li>Secondary bladder adenocarcinoma</li><li>Intestinal/enteric bladder adenocarcinoma</li><li>Clear cell adenocarcinoma</li><li>Signet-ring cell adenocarcinoma</li></ul></li><li><b>Urachal adenocarcinoma</b><ul><li>Mucinous urachal adenocarcinoma</li><li>Enteric urachal adenocarcinoma</li><li>Signet-ring cell urachal adenocarcinoma</li><li>Non-urachal bladder adenocarcinoma</li></ul></li><li><b>High-grade neuroendocrine carcinoma</b><ul><li>Pure small cell carcinoma (SmCC)</li><li>Mixed histology SmCC (with UC, adenocarcinoma, or SCC)</li></ul></li><li><b>Bladder sarcomas</b><ul><li>Leiomyosarcoma of the bladder</li><li>Rhabdomyosarcoma</li><li>Angiosarcomas</li></ul></li><li><b>Urothelial Carcinoma (UC) variants</b><ul><li>Urothelial with squamous differentiation</li><li>Urothelial with glandular differentiation</li><li>Nested variant</li><li>Microcystic variant</li><li>Micropapillary variant</li><li>Plasmacytoid/signet ring and lymphoma-like</li><li>Undifferentiated</li><li>Lymphoepithelioma-like</li><li>Clear cell variant</li><li>Lipid cell variant</li><li>Sarcomatoid or carcinosarcoma variants</li></ul></li><li><b>Plasmacytoid Urothelial Carcinoma (pUC)</b></li><li><b>Lymphoepithelioma-Like Carcinomas</b></li><li><b>Micropapillary Urothelial Carcinoma (mUC)</b></li><li><b>Nested Urothelial Carcinoma (nUC)</b></li><li><b>Nested Variant of Urothelial Carcinoma (NVUC)</b></li><li><b>Large Nested Urothelial Carcinoma (LNUC)</b></li><li><b>Carcinosarcoma (CS)</b></li></ul><p>Content solely for training and education purposes.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16256084-review-urinary-bladder-carcinoma-variants-a-conversational-discussion-0-28-00.mp3" length="17598225" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16256084</guid>
    <pubDate>Tue, 10 Dec 2024 14:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2173407/16256084/transcript" type="text/html" />
    <itunes:duration>1680</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Review: Non-Neoplastic Bone &amp; Joint Diseases (0:25:36)</itunes:title>
    <title>Review: Non-Neoplastic Bone &amp; Joint Diseases (0:25:36)</title>
    <itunes:summary><![CDATA[List of diagnostic entities discussed in this episode: Reactive and Reparative BoneFracturesCement LinesEnthesesOsteonecrosisDegenerative Joint DiseaseLoose BodiesSuperficial Subarticular Insufficiency FracturesRapidly Progressive/Rapidly Destructive ArthritisMetabolic Bone DiseaseInfections (Osteomyelitis and Bone Abscesses)Marrow FibrosisNon-neoplastic Soft Tissue AbnormalitiesMorton's NeuromaTraumatic NeuromaSoft Tissue Masses that May Simulate TumorsGoutCalcium Pyrophosphate Deposition Di...]]></itunes:summary>
    <description><![CDATA[<p>List of diagnostic entities discussed in this episode:</p><ul><li>Reactive and Reparative Bone</li><li>Fractures</li><li>Cement Lines</li><li>Entheses</li><li>Osteonecrosis</li><li>Degenerative Joint Disease</li><li>Loose Bodies</li><li>Superficial Subarticular Insufficiency Fractures</li><li>Rapidly Progressive/Rapidly Destructive Arthritis</li><li>Metabolic Bone Disease</li><li>Infections (Osteomyelitis and Bone Abscesses)</li><li>Marrow Fibrosis</li><li>Non-neoplastic Soft Tissue Abnormalities</li><li>Morton&apos;s Neuroma</li><li>Traumatic Neuroma</li><li>Soft Tissue Masses that May Simulate Tumors</li><li>Gout</li><li>Calcium Pyrophosphate Deposition Disease</li><li>Hydroxyapatite Deposition Disease/Tumoral Calcinosis</li><li>Neuropathic Joint/Charcot Joint</li></ul>]]></description>
    <content:encoded><![CDATA[<p>List of diagnostic entities discussed in this episode:</p><ul><li>Reactive and Reparative Bone</li><li>Fractures</li><li>Cement Lines</li><li>Entheses</li><li>Osteonecrosis</li><li>Degenerative Joint Disease</li><li>Loose Bodies</li><li>Superficial Subarticular Insufficiency Fractures</li><li>Rapidly Progressive/Rapidly Destructive Arthritis</li><li>Metabolic Bone Disease</li><li>Infections (Osteomyelitis and Bone Abscesses)</li><li>Marrow Fibrosis</li><li>Non-neoplastic Soft Tissue Abnormalities</li><li>Morton&apos;s Neuroma</li><li>Traumatic Neuroma</li><li>Soft Tissue Masses that May Simulate Tumors</li><li>Gout</li><li>Calcium Pyrophosphate Deposition Disease</li><li>Hydroxyapatite Deposition Disease/Tumoral Calcinosis</li><li>Neuropathic Joint/Charcot Joint</li></ul>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16241435-review-non-neoplastic-bone-joint-diseases-0-25-36.mp3" length="15585171" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16241435</guid>
    <pubDate>Sun, 08 Dec 2024 14:00:00 -0500</pubDate>
    <itunes:duration>1536</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review:  NIPBL-NACC1 Fusion in Cholangiocarcinoma (0:18:24)</itunes:title>
    <title>Mini-Review:  NIPBL-NACC1 Fusion in Cholangiocarcinoma (0:18:24)</title>
    <itunes:summary><![CDATA[Disclaimer The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. http://www.essentialpathol...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer </b>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p><a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16200359-mini-review-nipbl-nacc1-fusion-in-cholangiocarcinoma-0-18-24.mp3" length="13280477" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16200359</guid>
    <pubDate>Sun, 01 Dec 2024 09:00:00 -0500</pubDate>
    <itunes:duration>1104</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>MiniReview: Intrahepatic cholangiocarcinoma (iCCA) (0:06:10)</itunes:title>
    <title>MiniReview: Intrahepatic cholangiocarcinoma (iCCA) (0:06:10)</title>
    <itunes:summary><![CDATA[Feature Summary of iCCA in Keywords: Small duct iCCA: Mass forming. mucin-poor. CRP positive. BAP1, IDH1/2 mutation, and FGFR2 fusion.Large duct iCCA:  geographic infiltrative. mucin-producing columnar epithelium. S100P-positive. Mutations in K -ras and SMAD4.Cholangioblastic cholangiocarcinoma: Women. young age. neuroendocrine-like cytology. inhinbin-positive. and NIPBL-NACC1 gene fusion.]]></itunes:summary>
    <description><![CDATA[<p>Feature S<b>ummary of iCCA in Keywords:</b></p><ol><li>Small duct iCCA: Mass forming. mucin-poor. CRP positive. <em>BAP1</em>, <em>IDH1/2</em> mutation, and <em>FGFR2</em> fusion.</li><li>Large duct iCCA:  geographic infiltrative. mucin-producing columnar epithelium. S100P-positive. Mutations in <em>K -ras</em> and <em>SMAD4.</em></li><li>Cholangioblastic cholangiocarcinoma: Women. young age. neuroendocrine-like cytology. inhinbin-positive. and <em>NIPBL</em>-<em>NACC1</em> gene fusion.</li></ol>]]></description>
    <content:encoded><![CDATA[<p>Feature S<b>ummary of iCCA in Keywords:</b></p><ol><li>Small duct iCCA: Mass forming. mucin-poor. CRP positive. <em>BAP1</em>, <em>IDH1/2</em> mutation, and <em>FGFR2</em> fusion.</li><li>Large duct iCCA:  geographic infiltrative. mucin-producing columnar epithelium. S100P-positive. Mutations in <em>K -ras</em> and <em>SMAD4.</em></li><li>Cholangioblastic cholangiocarcinoma: Women. young age. neuroendocrine-like cytology. inhinbin-positive. and <em>NIPBL</em>-<em>NACC1</em> gene fusion.</li></ol>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/16146307-minireview-intrahepatic-cholangiocarcinoma-icca-0-06-10.mp3" length="4476410" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16146307</guid>
    <pubDate>Thu, 21 Nov 2024 07:00:00 -0500</pubDate>
    <itunes:duration>370</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Pancreas) Sample Study Questions, part-02 (0:10:11&quot;)</itunes:title>
    <title>(AIQz500 Pathology of the Pancreas) Sample Study Questions, part-02 (0:10:11&quot;)</title>
    <itunes:summary><![CDATA[Disclaimer This audio content is complimentary material to study book "AIQz500 Pathology of the Pancreas" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPat...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer</b><br/>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Pancreas&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. </p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer</b><br/>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Pancreas&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/15293037-aiqz500-pathology-of-the-pancreas-sample-study-questions-part-02-0-10-11.mp3" length="7362557" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15293037</guid>
    <pubDate>Sat, 22 Jun 2024 06:00:00 -0400</pubDate>
    <itunes:duration>611</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Pancreas) Sample Study Questions, part-01 (0:10:32&quot;)</itunes:title>
    <title>(AIQz500 Pathology of the Pancreas) Sample Study Questions, part-01 (0:10:32&quot;)</title>
    <itunes:summary><![CDATA[Disclaimer This audio content is complimentary material to study book "AIQz500 Pathology of the Pancreas" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPat...]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer</b><br/>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Pancreas&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer</b><br/>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Pancreas&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/15293028-aiqz500-pathology-of-the-pancreas-sample-study-questions-part-01-0-10-32.mp3" length="7611765" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15293028</guid>
    <pubDate>Sat, 22 Jun 2024 06:00:00 -0400</pubDate>
    <itunes:duration>632</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> AIQz500 Study Questions for Joint Pathology, part-02 (0:10:46&quot;)</itunes:title>
    <title> AIQz500 Study Questions for Joint Pathology, part-02 (0:10:46&quot;)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 Pathology Questions of Joint" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless Essentia...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology Questions of Joint&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology Questions of Joint&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/15155887-aiqz500-study-questions-for-joint-pathology-part-02-0-10-46.mp3" length="7781324" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15155887</guid>
    <pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
    <itunes:duration>646</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> AIQz500 Study Questions for Joint Pathology, part-01 (0:10:14&quot;)</itunes:title>
    <title> AIQz500 Study Questions for Joint Pathology, part-01 (0:10:14&quot;)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 Pathology Questions of Joint" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.  Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless Essenti...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology Questions of Joint&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. <br/><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology Questions of Joint&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. <br/><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/15155627-aiqz500-study-questions-for-joint-pathology-part-01-0-10-14.mp3" length="7394816" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15155627</guid>
    <pubDate>Wed, 29 May 2024 06:00:00 -0400</pubDate>
    <itunes:duration>614</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>bonus</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Lung) Sample Study Questions, part-02 (0:11:36&quot;)</itunes:title>
    <title>(AIQz500 Pathology of the Lung) Sample Study Questions, part-02 (0:11:36&quot;)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 Pathology of the Lung" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, L...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Lung&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Lung&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14975373-aiqz500-pathology-of-the-lung-sample-study-questions-part-02-0-11-36.mp3" length="8380070" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14975373</guid>
    <pubDate>Mon, 29 Apr 2024 10:00:00 -0400</pubDate>
    <itunes:duration>696</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>(AIQz500 Pathology of the Lung) Sample Study Questions, part-01 (0:11:41&quot;)</itunes:title>
    <title>(AIQz500 Pathology of the Lung) Sample Study Questions, part-01 (0:11:41&quot;)</title>
    <itunes:summary><![CDATA[This audio content is complimentary material to study book "AIQz500 Pathology of the Lung" (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved. The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, L...]]></itunes:summary>
    <description><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Lung&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>This audio content is complimentary material to study book &quot;AIQz500 Pathology of the Lung&quot; (2024). No portion of this audio can be reproduced and/or distributed. All rights reserved.<br/>The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14975354-aiqz500-pathology-of-the-lung-sample-study-questions-part-01-0-11-41.mp3" length="8438375" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14975354</guid>
    <pubDate>Mon, 29 Apr 2024 10:00:00 -0400</pubDate>
    <itunes:duration>701</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> Synopsis: Papillary Adenoma of the Lung (0:02:29&quot;)</itunes:title>
    <title> Synopsis: Papillary Adenoma of the Lung (0:02:29&quot;)</title>
    <itunes:summary><![CDATA[Feature Summary of Papillary Adenoma of the Lung.  •Exceedingly rare, benign peripheral lung tumor •Predominantly in man with wide age range •Circumscribed peripheral nodule •Papillary, fibrovascular cores •Single layer of bland lining epithelium •Positive for TTF1 and cytokeratins •Main differential diagnoses include alveolar adenoma, and adenocarcinoma •Complete resection curative   ]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of Papillary Adenoma of the Lung. <br/></b>•Exceedingly rare, benign peripheral lung tumor<br/>•Predominantly in man with wide age range<br/>•Circumscribed peripheral nodule<br/>•Papillary, fibrovascular cores<br/>•Single layer of bland lining epithelium<br/>•Positive for TTF1 and cytokeratins<br/>•Main differential diagnoses include alveolar adenoma, and adenocarcinoma<br/>•Complete resection curative<br/><br/></p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of Papillary Adenoma of the Lung. <br/></b>•Exceedingly rare, benign peripheral lung tumor<br/>•Predominantly in man with wide age range<br/>•Circumscribed peripheral nodule<br/>•Papillary, fibrovascular cores<br/>•Single layer of bland lining epithelium<br/>•Positive for TTF1 and cytokeratins<br/>•Main differential diagnoses include alveolar adenoma, and adenocarcinoma<br/>•Complete resection curative<br/><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14974857-synopsis-papillary-adenoma-of-the-lung-0-02-29.mp3" length="1817543" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14974857</guid>
    <pubDate>Mon, 29 Apr 2024 09:00:00 -0400</pubDate>
    <itunes:duration>149</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> Synopsis: Mucous gland adenoma of the lung (0:02:20&quot;)</itunes:title>
    <title> Synopsis: Mucous gland adenoma of the lung (0:02:20&quot;)</title>
    <itunes:summary><![CDATA[Key Feature Summary for Mucous gland adenoma:   • Rare benign proximal endobronchial tumor     • Airway obstruction symptoms common  • Exophytic, mucoid endobronchial nodules  • Cystic, acinar, tubular architecture    • Bland mucous cell lining, no atypia  • Positive for keratin, EMA, and CEA; low Ki-67 proliferation index • Main differential diagnosis: mucoepidermoid carcinoma, mucinous adenocarcinoma  • Cured by complete resection ]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary for Mucous gland adenoma: </b> <br/>• Rare benign proximal endobronchial tumor   <br/> • Airway obstruction symptoms common <br/>• Exophytic, mucoid endobronchial nodules<br/> • Cystic, acinar, tubular architecture   <br/>• Bland mucous cell lining, no atypia <br/>• Positive for keratin, EMA, and CEA; low Ki-67 proliferation index<br/>• Main differential diagnosis: mucoepidermoid carcinoma, mucinous adenocarcinoma <br/>• Cured by complete resection</p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary for Mucous gland adenoma: </b> <br/>• Rare benign proximal endobronchial tumor   <br/> • Airway obstruction symptoms common <br/>• Exophytic, mucoid endobronchial nodules<br/> • Cystic, acinar, tubular architecture   <br/>• Bland mucous cell lining, no atypia <br/>• Positive for keratin, EMA, and CEA; low Ki-67 proliferation index<br/>• Main differential diagnosis: mucoepidermoid carcinoma, mucinous adenocarcinoma <br/>• Cured by complete resection</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14974812-synopsis-mucous-gland-adenoma-of-the-lung-0-02-20.mp3" length="1712496" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14974812</guid>
    <pubDate>Mon, 29 Apr 2024 09:00:00 -0400</pubDate>
    <itunes:duration>140</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> Synopsis: Mucinous Cystadenoma of the lung (0:01:57&quot;)</itunes:title>
    <title> Synopsis: Mucinous Cystadenoma of the lung (0:01:57&quot;)</title>
    <itunes:summary><![CDATA[Key Feature Summary for Mucinous Cystadenoma of the Lung:  • Rare benign lung tumor usually found incidentally  • Mean age 60s, slightly more in women • Mucin-filled cyst lined by bland mucinous epithelium  • No atypia, invasion, or necrosis • Cytokeratin positive, and TTF1 negative  • Differential diagnosis include: Metastatic adenocarcinoma, colloid carcinoma, bronchogenic cyst. • Cured by complete surgical excision ]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary for Mucinous Cystadenoma of the Lung:</b> <br/>• Rare benign lung tumor usually found incidentally <br/>• Mean age 60s, slightly more in women<br/>• Mucin-filled cyst lined by bland mucinous epithelium <br/>• No atypia, invasion, or necrosis<br/>• Cytokeratin positive, and TTF1 negative <br/>• Differential diagnosis include: Metastatic adenocarcinoma, colloid carcinoma, bronchogenic cyst.<br/>• Cured by complete surgical excision</p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary for Mucinous Cystadenoma of the Lung:</b> <br/>• Rare benign lung tumor usually found incidentally <br/>• Mean age 60s, slightly more in women<br/>• Mucin-filled cyst lined by bland mucinous epithelium <br/>• No atypia, invasion, or necrosis<br/>• Cytokeratin positive, and TTF1 negative <br/>• Differential diagnosis include: Metastatic adenocarcinoma, colloid carcinoma, bronchogenic cyst.<br/>• Cured by complete surgical excision</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14974794-synopsis-mucinous-cystadenoma-of-the-lung-0-01-57.mp3" length="1430414" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14974794</guid>
    <pubDate>Mon, 29 Apr 2024 09:00:00 -0400</pubDate>
    <itunes:duration>117</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> Snippet: Lung Adenocarcinoma, Grading &amp; Behavior (0:02:25&quot;)</itunes:title>
    <title> Snippet: Lung Adenocarcinoma, Grading &amp; Behavior (0:02:25&quot;)</title>
    <itunes:summary><![CDATA[In summary,  lung adenocarcinoma grading is based on the predominant histological pattern. Immunophenotypes also reflect tumor behavior, but these immunophenotypic features are not incorporated in the current grading schema.     ]]></itunes:summary>
    <description><![CDATA[<p>In summary,  lung adenocarcinoma grading is based on the predominant histological pattern. Immunophenotypes also reflect tumor behavior, but these immunophenotypic features are not incorporated in the current grading schema.  <br/><br/></p>]]></description>
    <content:encoded><![CDATA[<p>In summary,  lung adenocarcinoma grading is based on the predominant histological pattern. Immunophenotypes also reflect tumor behavior, but these immunophenotypic features are not incorporated in the current grading schema.  <br/><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14974772-snippet-lung-adenocarcinoma-grading-behavior-0-02-25.mp3" length="1769913" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14974772</guid>
    <pubDate>Mon, 29 Apr 2024 09:00:00 -0400</pubDate>
    <itunes:duration>145</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Snippets: Pulmonary Small- vs Large-cell Neuroendocrine Carcinoma by IHC (0:02:20&quot;)</itunes:title>
    <title>Snippets: Pulmonary Small- vs Large-cell Neuroendocrine Carcinoma by IHC (0:02:20&quot;)</title>
    <itunes:summary><![CDATA[Key Points: Small-cell (neuroendocrine) carcinoma tends to be Rb1-negative and cyclin D1-negative, while large-cell carcinomas are largely positive for Rb1 and/or cyclin D1. The use of this simplified expression pattern leads to a diagnostic accuracy of 97.3%.   ]]></itunes:summary>
    <description><![CDATA[<p><b>Key Points:</b><br/>Small-cell (neuroendocrine) carcinoma tends to be Rb1-negative and cyclin D1-negative, while large-cell carcinomas are largely positive for Rb1 and/or cyclin D1. The use of this simplified expression pattern leads to a diagnostic accuracy of 97.3%.  </p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Points:</b><br/>Small-cell (neuroendocrine) carcinoma tends to be Rb1-negative and cyclin D1-negative, while large-cell carcinomas are largely positive for Rb1 and/or cyclin D1. The use of this simplified expression pattern leads to a diagnostic accuracy of 97.3%.  </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14974723-snippets-pulmonary-small-vs-large-cell-neuroendocrine-carcinoma-by-ihc-0-02-20.mp3" length="1705698" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14974723</guid>
    <pubDate>Mon, 29 Apr 2024 09:00:00 -0400</pubDate>
    <itunes:duration>140</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Adenocarcinoma in-situ (AIS) of the Lung (0:02:34&quot;)</itunes:title>
    <title>Synopsis: Adenocarcinoma in-situ (AIS) of the Lung (0:02:34&quot;)</title>
    <itunes:summary><![CDATA[Key Feature Summary of  Adenocarcinoma in situ (AIS) • Localized adenocarcinoma, ≤3 cm,  • Ground glass nodule  on CT  • Lepidic growth of tumor cells along alveolar walls   • Bland cytology without invasion   • ≥50% EGFR mutation rate   • 100% 5yr disease-free survival after complete resection ]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary of  Adenocarcinoma in situ (AIS)</b><br/>• Localized adenocarcinoma, ≤3 cm, <br/>• Ground glass nodule  on CT <br/>• Lepidic growth of tumor cells along alveolar walls  <br/>• Bland cytology without invasion  <br/>• ≥50% EGFR mutation rate  <br/>• 100% 5yr disease-free survival after complete resection</p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary of  Adenocarcinoma in situ (AIS)</b><br/>• Localized adenocarcinoma, ≤3 cm, <br/>• Ground glass nodule  on CT <br/>• Lepidic growth of tumor cells along alveolar walls  <br/>• Bland cytology without invasion  <br/>• ≥50% EGFR mutation rate  <br/>• 100% 5yr disease-free survival after complete resection</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14974700-synopsis-adenocarcinoma-in-situ-ais-of-the-lung-0-02-34.mp3" length="1882764" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14974700</guid>
    <pubDate>Mon, 29 Apr 2024 09:00:00 -0400</pubDate>
    <itunes:duration>154</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Immune Checkpoint Inhibitors (ICPI s) &amp; Colitis (05:04&quot;)</itunes:title>
    <title>Mini-Review: Immune Checkpoint Inhibitors (ICPI s) &amp; Colitis (05:04&quot;)</title>
    <itunes:summary><![CDATA[Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14863251-mini-review-immune-checkpoint-inhibitors-icpi-s-colitis-05-04.mp3" length="3683664" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14863251</guid>
    <pubDate>Wed, 10 Apr 2024 06:00:00 -0400</pubDate>
    <itunes:duration>304</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Autoimmune Pancreatitis (Type I and Type II) (05:32&quot;)</itunes:title>
    <title>Mini-Review: Autoimmune Pancreatitis (Type I and Type II) (05:32&quot;)</title>
    <itunes:summary><![CDATA[Feature Summary:  There are two distinct subtypes of autoimmune pancreatitis (AIP).  AIP-1: AIP-1 belongs to the group of IgG4-related diseases histologically characterized by storiform cellular fibrosis, obliterative phlebitis, and periductal chronic inflammation rich in IgG4-positive plasma cells.  AIP-2:  AIP-2: also known as idiopathic duct-centric pancreatitis, characterized by Ductal inflammation with intraepithelial neutrophils (so-called, granulocytic epithelial lesion), luminal ...]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary: </b><br/>There are two distinct subtypes of autoimmune pancreatitis (AIP).<br/><br/>AIP-1: AIP-1 belongs to the group of IgG4-related diseases histologically characterized by storiform cellular fibrosis, obliterative phlebitis, and periductal chronic inflammation rich in IgG4-positive plasma cells.<br/><br/>AIP-2:  AIP-2: also known as idiopathic duct-centric pancreatitis, characterized by Ductal inflammation with intraepithelial neutrophils (so-called, granulocytic epithelial lesion), luminal neutrophilic abscesses, extensive fibrosis, but no apparent storiform or hypercellularity. </p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary: </b><br/>There are two distinct subtypes of autoimmune pancreatitis (AIP).<br/><br/>AIP-1: AIP-1 belongs to the group of IgG4-related diseases histologically characterized by storiform cellular fibrosis, obliterative phlebitis, and periductal chronic inflammation rich in IgG4-positive plasma cells.<br/><br/>AIP-2:  AIP-2: also known as idiopathic duct-centric pancreatitis, characterized by Ductal inflammation with intraepithelial neutrophils (so-called, granulocytic epithelial lesion), luminal neutrophilic abscesses, extensive fibrosis, but no apparent storiform or hypercellularity. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14862950-mini-review-autoimmune-pancreatitis-type-i-and-type-ii-05-32.mp3" length="4019383" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14862950</guid>
    <pubDate>Wed, 10 Apr 2024 06:00:00 -0400</pubDate>
    <itunes:duration>332</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> Synopsis: Cholangioblastic cholangiocarcinoma (02:29&quot;)</itunes:title>
    <title> Synopsis: Cholangioblastic cholangiocarcinoma (02:29&quot;)</title>
    <itunes:summary><![CDATA[Summary in Keyword Young women. bimorphic cytology. positive for inhibin-A. unique NIPBL-NACC1 gene fusion. ]]></itunes:summary>
    <description><![CDATA[<p><b>Summary in Keyword</b></p><p>Young women. bimorphic cytology. positive for inhibin-A. unique <em>NIPBL</em>-<em>NACC1</em> gene fusion.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Summary in Keyword</b></p><p>Young women. bimorphic cytology. positive for inhibin-A. unique <em>NIPBL</em>-<em>NACC1</em> gene fusion.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14832868-synopsis-cholangioblastic-cholangiocarcinoma-02-29.mp3" length="1820283" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14832868</guid>
    <pubDate>Fri, 05 Apr 2024 06:00:00 -0400</pubDate>
    <itunes:duration>149</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> Mini-Review: Hepatoid Tumors (HTs) are not Hepatocellular Carcinoma (03:46&quot;)</itunes:title>
    <title> Mini-Review: Hepatoid Tumors (HTs) are not Hepatocellular Carcinoma (03:46&quot;)</title>
    <itunes:summary><![CDATA[Feature Summary of Hepatoid Tumors Histologically similar to hepatocellular carcinoma (HCC) but arises outside the liver. Most commonly arise in the gastrointestinal tract and pancreaticobiliary system. Hepatocellular differentiation marked by positive immunostains for heppar-1, arginase-1,  CD10 in canalicular pattern, and, to a greater extent, alfa-fetal protein and glypican-3. Largely classified as a form of adenocarcinoma rather than a specific entity. In contrast...]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of Hepatoid Tumors</b></p><ul><li>Histologically similar to hepatocellular carcinoma (HCC) but arises outside the liver. </li><li>Most commonly arise in the gastrointestinal tract and pancreaticobiliary system. </li><li>Hepatocellular differentiation marked by positive immunostains for heppar-1, arginase-1,  CD10 in canalicular pattern, and, to a greater extent, alfa-fetal protein and glypican-3. </li><li>Largely classified as a form of adenocarcinoma rather than a specific entity. </li><li>In contrast to hepatocellular carcinoma, they are positive for SALL-4, and CK19. </li><li>Overall they are aggressive malignant neoplasm. </li></ul>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of Hepatoid Tumors</b></p><ul><li>Histologically similar to hepatocellular carcinoma (HCC) but arises outside the liver. </li><li>Most commonly arise in the gastrointestinal tract and pancreaticobiliary system. </li><li>Hepatocellular differentiation marked by positive immunostains for heppar-1, arginase-1,  CD10 in canalicular pattern, and, to a greater extent, alfa-fetal protein and glypican-3. </li><li>Largely classified as a form of adenocarcinoma rather than a specific entity. </li><li>In contrast to hepatocellular carcinoma, they are positive for SALL-4, and CK19. </li><li>Overall they are aggressive malignant neoplasm. </li></ul>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14832848-mini-review-hepatoid-tumors-hts-are-not-hepatocellular-carcinoma-03-46.mp3" length="2744504" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14832848</guid>
    <pubDate>Fri, 05 Apr 2024 06:00:00 -0400</pubDate>
    <itunes:duration>226</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Macroscopic Subtypes of Hepatocellular Carcinoma (05:15&quot;)</itunes:title>
    <title>Mini-Review: Macroscopic Subtypes of Hepatocellular Carcinoma (05:15&quot;)</title>
    <itunes:summary><![CDATA[Summary HCC can be classified into five macroscopic types based on their gross morphology. They are associated with different extents of metastasis and thus different clinical outcomes. ]]></itunes:summary>
    <description><![CDATA[<p><b>Summary</b><br/>HCC can be classified into five macroscopic types based on their gross morphology. They are associated with different extents of metastasis and thus different clinical outcomes.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Summary</b><br/>HCC can be classified into five macroscopic types based on their gross morphology. They are associated with different extents of metastasis and thus different clinical outcomes.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14832838-mini-review-macroscopic-subtypes-of-hepatocellular-carcinoma-05-15.mp3" length="3837175" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14832838</guid>
    <pubDate>Fri, 05 Apr 2024 06:00:00 -0400</pubDate>
    <itunes:duration>317</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Snippets Olfactory Carcinoma (01:02&quot;)</itunes:title>
    <title>Snippets Olfactory Carcinoma (01:02&quot;)</title>
    <itunes:summary><![CDATA[Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast. ]]></itunes:summary>
    <description><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14832818-snippets-olfactory-carcinoma-01-02.mp3" length="779931" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14832818</guid>
    <pubDate>Fri, 05 Apr 2024 06:00:00 -0400</pubDate>
    <itunes:duration>62</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Snippets: Intracholecystic &amp; Intraductal Papillary Neoplasms of the Biliary Tree (02:22)</itunes:title>
    <title>Snippets: Intracholecystic &amp; Intraductal Papillary Neoplasms of the Biliary Tree (02:22)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/ Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and exp...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14576501-snippets-intracholecystic-intraductal-papillary-neoplasms-of-the-biliary-tree-02-22.mp3" length="1735399" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14576501</guid>
    <pubDate>Mon, 26 Feb 2024 06:00:00 -0500</pubDate>
    <itunes:duration>142</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Thymic Carcinomas (03:45)</itunes:title>
    <title>Synopsis: Thymic Carcinomas (03:45)</title>
    <itunes:summary><![CDATA[Feature Summary of Thymic Carcinomas   Thymic carcinomas are histologically similar to their counterparts arising in other organ sites; and their diagnosis relies on  1) anterior mediastinal location,  2) lack of carcinoma of other organ sites,  3) co-existing lymphocytic component, and  4) immunophenotypes of thymic origin.   ]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of Thymic Carcinomas </b><br/><br/>Thymic carcinomas are histologically similar to their counterparts arising in other organ sites; and their diagnosis relies on <br/>1) anterior mediastinal location, <br/>2) lack of carcinoma of other organ sites, <br/>3) co-existing lymphocytic component, and <br/>4) immunophenotypes of thymic origin.  </p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of Thymic Carcinomas </b><br/><br/>Thymic carcinomas are histologically similar to their counterparts arising in other organ sites; and their diagnosis relies on <br/>1) anterior mediastinal location, <br/>2) lack of carcinoma of other organ sites, <br/>3) co-existing lymphocytic component, and <br/>4) immunophenotypes of thymic origin.  </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14576470-synopsis-thymic-carcinomas-03-45.mp3" length="2727108" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14576470</guid>
    <pubDate>Mon, 26 Feb 2024 06:00:00 -0500</pubDate>
    <itunes:duration>225</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-review: Cutaneous Melanocytic Tumor With CRTC1 &amp; TRIM 11 Translocation (03:35)</itunes:title>
    <title>Mini-review: Cutaneous Melanocytic Tumor With CRTC1 &amp; TRIM 11 Translocation (03:35)</title>
    <itunes:summary><![CDATA[Feature Summary of CMTCT -- A novel pathologic entity of melanocytic origin, -- Variable positive immunostains for S100-protein, HMB45, and Melan-A. -- Diffusely positive stains for SOX10, MITF, and TRIM11 -- CRTC1 &amp; TRIM11 fusion is a signature genetic alteration. -- Seems to be a low-grade indolent tumor with malignant potential. ]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of CMTCT</b><br/>-- A novel pathologic entity of melanocytic origin,<br/>-- Variable positive immunostains for S100-protein, HMB45, and Melan-A.<br/>-- Diffusely positive stains for SOX10, MITF, and TRIM11<br/>-- CRTC1 &amp; TRIM11 fusion is a signature genetic alteration.<br/>-- Seems to be a low-grade indolent tumor with malignant potential.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of CMTCT</b><br/>-- A novel pathologic entity of melanocytic origin,<br/>-- Variable positive immunostains for S100-protein, HMB45, and Melan-A.<br/>-- Diffusely positive stains for SOX10, MITF, and TRIM11<br/>-- CRTC1 &amp; TRIM11 fusion is a signature genetic alteration.<br/>-- Seems to be a low-grade indolent tumor with malignant potential.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14456856-mini-review-cutaneous-melanocytic-tumor-with-crtc1-trim-11-translocation-03-35.mp3" length="2611536" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14456856</guid>
    <pubDate>Wed, 07 Feb 2024 05:00:00 -0500</pubDate>
    <itunes:duration>215</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Gallbladder Carcinomas and Differential Diagnosis (05:02)</itunes:title>
    <title>Mini-Review: Gallbladder Carcinomas and Differential Diagnosis (05:02)</title>
    <itunes:summary><![CDATA[Features of Gallbladder Carcinomas -- The fifth most common cancers of the gastrointestinal tract. -- Poor prognosis and very low overall 5-year survival rates of  less than 5%.  -- The most common type is adenocarcinomas. -- Adenocarcinomas usually are positive for IMP3, S100P, and Maspin. -- The pathologic staging differs from that of other carcinomas in the GI tract. ]]></itunes:summary>
    <description><![CDATA[<p><b>Features of Gallbladder Carcinomas</b><br/>-- The fifth most common cancers of the gastrointestinal tract.<br/>-- Poor prognosis and very low overall 5-year survival rates of  less than 5%. <br/>-- The most common type is adenocarcinomas.<br/>-- Adenocarcinomas usually are positive for IMP3, S100P, and Maspin.<br/>-- The pathologic staging differs from that of other carcinomas in the GI tract.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Features of Gallbladder Carcinomas</b><br/>-- The fifth most common cancers of the gastrointestinal tract.<br/>-- Poor prognosis and very low overall 5-year survival rates of  less than 5%. <br/>-- The most common type is adenocarcinomas.<br/>-- Adenocarcinomas usually are positive for IMP3, S100P, and Maspin.<br/>-- The pathologic staging differs from that of other carcinomas in the GI tract.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14456838-mini-review-gallbladder-carcinomas-and-differential-diagnosis-05-02.mp3" length="3654109" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14456838</guid>
    <pubDate>Wed, 07 Feb 2024 05:00:00 -0500</pubDate>
    <itunes:duration>302</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Snippets: Olfactory Carcinoma (01:02)</itunes:title>
    <title>Snippets: Olfactory Carcinoma (01:02)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/  Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and ex...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a><br/><br/><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a><br/><br/><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14456823-snippets-olfactory-carcinoma-01-02.mp3" length="779931" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14456823</guid>
    <pubDate>Wed, 07 Feb 2024 05:00:00 -0500</pubDate>
    <itunes:duration>62</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Ovarian leydig cell tumor (0:01:55)</itunes:title>
    <title>Synopsis: Ovarian leydig cell tumor (0:01:55)</title>
    <itunes:summary><![CDATA[Feature Summary of Ovarian leydig cell tumor:  Well circumscribe solid nodule near ovarian hylum Fusion of cytoplasm to form nuclear-free zones is a key feature Cytoplasmic Reinke crystals and lipochrome pigments Fibrinoid material in blood vessels Typically positive for inhibin, calretinin, and mellan-A ]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of Ovarian leydig cell tumor:</b></p><ul><li> Well circumscribe solid nodule near ovarian hylum </li><li>Fusion of cytoplasm to form nuclear-free zones is a key feature </li><li>Cytoplasmic Reinke crystals and lipochrome pigments </li><li>Fibrinoid material in blood vessels </li><li>Typically positive for inhibin, calretinin, and mellan-A </li></ul>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of Ovarian leydig cell tumor:</b></p><ul><li> Well circumscribe solid nodule near ovarian hylum </li><li>Fusion of cytoplasm to form nuclear-free zones is a key feature </li><li>Cytoplasmic Reinke crystals and lipochrome pigments </li><li>Fibrinoid material in blood vessels </li><li>Typically positive for inhibin, calretinin, and mellan-A </li></ul>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14405063-synopsis-ovarian-leydig-cell-tumor-0-01-55.mp3" length="1417562" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14405063</guid>
    <pubDate>Tue, 30 Jan 2024 08:00:00 -0500</pubDate>
    <itunes:duration>115</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Ovarian Mucinous Tumors (05:01)</itunes:title>
    <title>Mini-Review: Ovarian Mucinous Tumors (05:01)</title>
    <itunes:summary><![CDATA[Summary of Ovarian mucinous tumors (OMT) This mini-review highlights features of five forms of OMTs: 1.  Mucinous borderline tumor (MBT).2.  MBT with microinvasion.3.  MBT with intraepithelial carcinoma.4.  Mucinous carcinoma with destructive infiltrative invasion.5.  Mucinous carcinoma with confluent/expansile invasion. Ovarian mucinous carcinoma must be distinguished from metastatic carcinoma with mucinous differentiation. ]]></itunes:summary>
    <description><![CDATA[<p><b>Summary of Ovarian mucinous tumors (OMT)</b><br/>This mini-review highlights features of five forms of OMTs:</p><ul><li>1.  Mucinous borderline tumor (MBT).</li><li>2.  MBT with microinvasion.</li><li>3.  MBT with intraepithelial carcinoma.</li><li>4.  Mucinous carcinoma with destructive infiltrative invasion.</li><li>5.  Mucinous carcinoma with confluent/expansile invasion. </li></ul><p>Ovarian mucinous carcinoma must be distinguished from metastatic carcinoma with mucinous differentiation.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Summary of Ovarian mucinous tumors (OMT)</b><br/>This mini-review highlights features of five forms of OMTs:</p><ul><li>1.  Mucinous borderline tumor (MBT).</li><li>2.  MBT with microinvasion.</li><li>3.  MBT with intraepithelial carcinoma.</li><li>4.  Mucinous carcinoma with destructive infiltrative invasion.</li><li>5.  Mucinous carcinoma with confluent/expansile invasion. </li></ul><p>Ovarian mucinous carcinoma must be distinguished from metastatic carcinoma with mucinous differentiation.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14405048-mini-review-ovarian-mucinous-tumors-05-01.mp3" length="3649982" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14405048</guid>
    <pubDate>Tue, 30 Jan 2024 08:00:00 -0500</pubDate>
    <itunes:duration>301</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Autoimmune Pancreatitis (Type I and Type II) (05:32)</itunes:title>
    <title>Mini-Review: Autoimmune Pancreatitis (Type I and Type II) (05:32)</title>
    <itunes:summary><![CDATA[Summary of Autoimmune pancreatitis  Autoimmune pancreatitis (AIP) is a chronic fibroinflammatory disease characterized by prompt response to steroid therapy. AIP presents as two distinct subtypes. AIP-1: AIP-1 belongs to the group of IgG4-related diseases histologically characterized by storiform cellular fibrosis, obliterative phlebitis, and periductal chronic inflammation rich in IgG4-positive plasma cells.AIP-2:  AIP-2: also known as idiopathic duct-centric pancreatitis, characterized...]]></itunes:summary>
    <description><![CDATA[<p><b>Summary of Autoimmune pancreatitis</b><br/><br/>Autoimmune pancreatitis (AIP) is a chronic fibroinflammatory disease characterized by prompt response to steroid therapy. AIP presents as two distinct subtypes.</p><ul><li>AIP-1: AIP-1 belongs to the group of IgG4-related diseases histologically characterized by storiform cellular fibrosis, obliterative phlebitis, and periductal chronic inflammation rich in IgG4-positive plasma cells.</li><li>AIP-2:  AIP-2: also known as idiopathic duct-centric pancreatitis, characterized by Ductal inflammation with intraepithelial neutrophils (so-called, granulocytic epithelial lesion), luminal neutrophilic abscesses, extensive fibrosis, but no apparent storiform or hypercellularity. </li></ul>]]></description>
    <content:encoded><![CDATA[<p><b>Summary of Autoimmune pancreatitis</b><br/><br/>Autoimmune pancreatitis (AIP) is a chronic fibroinflammatory disease characterized by prompt response to steroid therapy. AIP presents as two distinct subtypes.</p><ul><li>AIP-1: AIP-1 belongs to the group of IgG4-related diseases histologically characterized by storiform cellular fibrosis, obliterative phlebitis, and periductal chronic inflammation rich in IgG4-positive plasma cells.</li><li>AIP-2:  AIP-2: also known as idiopathic duct-centric pancreatitis, characterized by Ductal inflammation with intraepithelial neutrophils (so-called, granulocytic epithelial lesion), luminal neutrophilic abscesses, extensive fibrosis, but no apparent storiform or hypercellularity. </li></ul>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14405028-mini-review-autoimmune-pancreatitis-type-i-and-type-ii-05-32.mp3" length="4020544" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14405028</guid>
    <pubDate>Tue, 30 Jan 2024 08:00:00 -0500</pubDate>
    <itunes:duration>332</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Hepatoid Tumors (HTs) are not Hepatocellular Carcinoma (03:46)</itunes:title>
    <title>Mini-Review: Hepatoid Tumors (HTs) are not Hepatocellular Carcinoma (03:46)</title>
    <itunes:summary><![CDATA[Feature Summary of Hepatoid Tumors  Histologically similar to hepatocellular carcinoma (HCC) but arises outside the liver. Most commonly arise in the gastrointestinal tract and pancreaticobiliary system. Hepatocellular differentiation marked by positive immunostains for heppar-1, arginase-1,  CD10 in canalicular pattern, and, to a greater extent, alfa-fetal protein and glypican-3. Largely classified as a form of adenocarcinoma rather than a specific entity. In contras...]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of Hepatoid Tumors </b></p><ul><li>Histologically similar to hepatocellular carcinoma (HCC) but arises outside the liver. </li><li>Most commonly arise in the gastrointestinal tract and pancreaticobiliary system. </li><li>Hepatocellular differentiation marked by positive immunostains for heppar-1, arginase-1,  CD10 in canalicular pattern, and, to a greater extent, alfa-fetal protein and glypican-3. </li><li>Largely classified as a form of adenocarcinoma rather than a specific entity. </li><li>In contrast to hepatocellular carcinoma, they are positive for SALL-4, and CK19. </li><li>Overall they are aggressive malignant neoplasm. </li></ul><p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of Hepatoid Tumors </b></p><ul><li>Histologically similar to hepatocellular carcinoma (HCC) but arises outside the liver. </li><li>Most commonly arise in the gastrointestinal tract and pancreaticobiliary system. </li><li>Hepatocellular differentiation marked by positive immunostains for heppar-1, arginase-1,  CD10 in canalicular pattern, and, to a greater extent, alfa-fetal protein and glypican-3. </li><li>Largely classified as a form of adenocarcinoma rather than a specific entity. </li><li>In contrast to hepatocellular carcinoma, they are positive for SALL-4, and CK19. </li><li>Overall they are aggressive malignant neoplasm. </li></ul><p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14367602-mini-review-hepatoid-tumors-hts-are-not-hepatocellular-carcinoma-03-46.mp3" length="2744500" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14367602</guid>
    <pubDate>Wed, 24 Jan 2024 06:00:00 -0500</pubDate>
    <itunes:duration>226</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Papillary Adenoma of the Lung (02:29)</itunes:title>
    <title>Synopsis: Papillary Adenoma of the Lung (02:29)</title>
    <itunes:summary><![CDATA[Feature Summary of Papillary Adenoma   Exceedingly rare, benign peripheral lung tumorPredominantly in man with wide age rangeCircumscribed peripheral nodulePapillary, fibrovascular coresSingle layer of bland lining epitheliumPositive for TTF1 and cytokeratinsMain differential diagnoses include alveolar adenoma, and adenocarcinomaComplete resection curativePlease visit us at:  http://www.EssentialPathology.info  ]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of Papillary Adenoma  </b></p><ul><li>Exceedingly rare, benign peripheral lung tumor</li><li>Predominantly in man with wide age range</li><li>Circumscribed peripheral nodule</li><li>Papillary, fibrovascular cores</li><li>Single layer of bland lining epithelium</li><li>Positive for TTF1 and cytokeratins</li><li>Main differential diagnoses include alveolar adenoma, and adenocarcinoma</li><li>Complete resection curative</li></ul><p>Please visit us at:  http://www.EssentialPathology.info </p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of Papillary Adenoma  </b></p><ul><li>Exceedingly rare, benign peripheral lung tumor</li><li>Predominantly in man with wide age range</li><li>Circumscribed peripheral nodule</li><li>Papillary, fibrovascular cores</li><li>Single layer of bland lining epithelium</li><li>Positive for TTF1 and cytokeratins</li><li>Main differential diagnoses include alveolar adenoma, and adenocarcinoma</li><li>Complete resection curative</li></ul><p>Please visit us at:  http://www.EssentialPathology.info </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14344020-synopsis-papillary-adenoma-of-the-lung-02-29.mp3" length="1818698" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14344020</guid>
    <pubDate>Sat, 20 Jan 2024 11:00:00 -0500</pubDate>
    <itunes:duration>149</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Mucous gland adenoma of the lung (02:20)</itunes:title>
    <title>Synopsis: Mucous gland adenoma of the lung (02:20)</title>
    <itunes:summary><![CDATA[Key Feature Summary for Mucous gland adenoma   Rare benign proximal endobronchial tumor    Airway obstruction symptoms common  Exophytic, mucoid endobronchial nodules Cystic, acinar, tubular architecture    Bland mucous cell lining, no atypia  Positive for keratin, EMA, and CEA; low Ki-67 proliferation index Main differential diagnosis: mucoepidermoid carcinoma, mucinous adenocarcinoma Cured by complete resectionPlease visi...]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary for Mucous gland adenoma  </b></p><ul><li>Rare benign proximal endobronchial tumor   </li><li> Airway obstruction symptoms common </li><li> Exophytic, mucoid endobronchial nodules</li><li> Cystic, acinar, tubular architecture   </li><li> Bland mucous cell lining, no atypia </li><li> Positive for keratin, EMA, and CEA; low Ki-67 proliferation index</li><li> Main differential diagnosis: mucoepidermoid carcinoma, mucinous adenocarcinoma </li><li>Cured by complete resection</li></ul><p>Please visit us at:  http://www.EssentialPathology.info </p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary for Mucous gland adenoma  </b></p><ul><li>Rare benign proximal endobronchial tumor   </li><li> Airway obstruction symptoms common </li><li> Exophytic, mucoid endobronchial nodules</li><li> Cystic, acinar, tubular architecture   </li><li> Bland mucous cell lining, no atypia </li><li> Positive for keratin, EMA, and CEA; low Ki-67 proliferation index</li><li> Main differential diagnosis: mucoepidermoid carcinoma, mucinous adenocarcinoma </li><li>Cured by complete resection</li></ul><p>Please visit us at:  http://www.EssentialPathology.info </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14343995-synopsis-mucous-gland-adenoma-of-the-lung-02-20.mp3" length="1713651" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14343995</guid>
    <pubDate>Sat, 20 Jan 2024 10:00:00 -0500</pubDate>
    <itunes:duration>140</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Mucinous Cystadenoma of the lung (01:57)</itunes:title>
    <title>Synopsis: Mucinous Cystadenoma of the lung (01:57)</title>
    <itunes:summary><![CDATA[Key Feature Summary for Mucinous Cystadenoma of the Lung  Rare benign lung tumor usually found incidentally  Mean age 60s, slightly more in women Mucin-filled cyst lined by bland mucinous epithelium  No atypia, invasion, or necrosis Cytokeratin positive, and TTF1 negative  Differential diagnosis include: Metastatic adenocarcinoma, colloid carcinoma, bronchogenic cyst. Cured by complete surgical excisionPlease visit us at:  http://www.Essential...]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary for Mucinous Cystadenoma of the Lung </b></p><ul><li>Rare benign lung tumor usually found incidentally </li><li> Mean age 60s, slightly more in women</li><li> Mucin-filled cyst lined by bland mucinous epithelium </li><li> No atypia, invasion, or necrosis</li><li> Cytokeratin positive, and TTF1 negative </li><li> Differential diagnosis include: Metastatic adenocarcinoma, colloid carcinoma, bronchogenic cyst.</li><li> Cured by complete surgical excision</li></ul><p>Please visit us at:  http://www.EssentialPathology.info </p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary for Mucinous Cystadenoma of the Lung </b></p><ul><li>Rare benign lung tumor usually found incidentally </li><li> Mean age 60s, slightly more in women</li><li> Mucin-filled cyst lined by bland mucinous epithelium </li><li> No atypia, invasion, or necrosis</li><li> Cytokeratin positive, and TTF1 negative </li><li> Differential diagnosis include: Metastatic adenocarcinoma, colloid carcinoma, bronchogenic cyst.</li><li> Cured by complete surgical excision</li></ul><p>Please visit us at:  http://www.EssentialPathology.info </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14343972-synopsis-mucinous-cystadenoma-of-the-lung-01-57.mp3" length="1431569" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14343972</guid>
    <pubDate>Sat, 20 Jan 2024 10:00:00 -0500</pubDate>
    <itunes:duration>117</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Adenocarcinoma in-situ  (AIS) of the Lung (02:34)</itunes:title>
    <title>Synopsis: Adenocarcinoma in-situ  (AIS) of the Lung (02:34)</title>
    <itunes:summary><![CDATA[Key Feature Summary of  Adenocarcinoma in situ (AIS) Localized adenocarcinoma, ≤3 cm,  Ground glass nodule  on CT  Lepidic growth of tumor cells along alveolar walls   Bland cytology without invasion   ≥50% EGFR mutation rate   100% 5yr disease-free survival after complete resectionPlease visit us at:  http://www.EssentialPathology.info  ]]></itunes:summary>
    <description><![CDATA[<p><b>Key Feature Summary of  Adenocarcinoma in situ (AIS)</b></p><ul><li>Localized adenocarcinoma, ≤3 cm, </li><li> Ground glass nodule  on CT </li><li> Lepidic growth of tumor cells along alveolar walls  </li><li> Bland cytology without invasion  </li><li> ≥50% EGFR mutation rate  </li><li> 100% 5yr disease-free survival after complete resection</li></ul><p>Please visit us at:  http://www.EssentialPathology.info </p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Feature Summary of  Adenocarcinoma in situ (AIS)</b></p><ul><li>Localized adenocarcinoma, ≤3 cm, </li><li> Ground glass nodule  on CT </li><li> Lepidic growth of tumor cells along alveolar walls  </li><li> Bland cytology without invasion  </li><li> ≥50% EGFR mutation rate  </li><li> 100% 5yr disease-free survival after complete resection</li></ul><p>Please visit us at:  http://www.EssentialPathology.info </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14343882-synopsis-adenocarcinoma-in-situ-ais-of-the-lung-02-34.mp3" length="1883923" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14343882</guid>
    <pubDate>Sat, 20 Jan 2024 10:00:00 -0500</pubDate>
    <itunes:duration>154</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Thymoma (part-B) (05:20)</itunes:title>
    <title>Mini-Review: Thymoma (part-B) (05:20)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/ Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and exp...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14324042-mini-review-thymoma-part-b-05-20.mp3" length="3868140" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14324042</guid>
    <pubDate>Tue, 16 Jan 2024 20:00:00 -0500</pubDate>
    <itunes:duration>320</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Thymomas (part-A) (05:14)</itunes:title>
    <title>Mini-Review: Thymomas (part-A) (05:14)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/ Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and exp...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14324021-mini-review-thymomas-part-a-05-14.mp3" length="3798866" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14324021</guid>
    <pubDate>Tue, 16 Jan 2024 20:00:00 -0500</pubDate>
    <itunes:duration>314</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Thymic Micronodular Tumors with Lymphoid Hyperplasia (03:35)</itunes:title>
    <title>Synopsis: Thymic Micronodular Tumors with Lymphoid Hyperplasia (03:35)</title>
    <itunes:summary><![CDATA[Feature Summary: The key contrasting features of micronodular thymoma (MT) and Micronodular thymic carcinoma (MTC) are cytological atypia, tumor necrosis, mitotic activities, intratumoral TdT-positive lymphocytes, CD5, CD117, and Glut-1 expression.  ]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary:</b><br/>The key contrasting features of micronodular thymoma (MT) and Micronodular thymic carcinoma (MTC) are cytological atypia, tumor necrosis, mitotic activities, intratumoral TdT-positive lymphocytes, CD5, CD117, and Glut-1 expression. </p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary:</b><br/>The key contrasting features of micronodular thymoma (MT) and Micronodular thymic carcinoma (MTC) are cytological atypia, tumor necrosis, mitotic activities, intratumoral TdT-positive lymphocytes, CD5, CD117, and Glut-1 expression. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14324003-synopsis-thymic-micronodular-tumors-with-lymphoid-hyperplasia-03-35.mp3" length="2615585" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14324003</guid>
    <pubDate>Tue, 16 Jan 2024 20:00:00 -0500</pubDate>
    <itunes:duration>215</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Ovarian Serous Borderline Tumors (04:08)</itunes:title>
    <title>Mini-Review: Ovarian Serous Borderline Tumors (04:08)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/ Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and exp...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14277743-mini-review-ovarian-serous-borderline-tumors-04-08.mp3" length="3005778" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14277743</guid>
    <pubDate>Tue, 09 Jan 2024 06:00:00 -0500</pubDate>
    <itunes:duration>248</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Breast Papillary Tumors (A Short Overview) (07:03)</itunes:title>
    <title>Mini-Review: Breast Papillary Tumors (A Short Overview) (07:03)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/ Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and exp...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p> </p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p><b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p><p> </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14267368-mini-review-breast-papillary-tumors-a-short-overview-07-03.mp3" length="5112668" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14267368</guid>
    <pubDate>Sun, 07 Jan 2024 19:00:00 -0500</pubDate>
    <itunes:duration>423</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title> Mini-Review: Macroscopic Subtypes of Hepatocellular Carcinoma (05:15)</itunes:title>
    <title> Mini-Review: Macroscopic Subtypes of Hepatocellular Carcinoma (05:15)</title>
    <itunes:summary><![CDATA[Summary Hepatocellular carcinoma (HCC) can be classified into five macroscopic types based on their gross morphology. They are associated with different potential and extents of metastasis and thus different clinical outcomes. ]]></itunes:summary>
    <description><![CDATA[<p><b>Summary</b><br/>Hepatocellular carcinoma (HCC) can be classified into five macroscopic types based on their gross morphology. They are associated with different potential and extents of metastasis and thus different clinical outcomes.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Summary</b><br/>Hepatocellular carcinoma (HCC) can be classified into five macroscopic types based on their gross morphology. They are associated with different potential and extents of metastasis and thus different clinical outcomes.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14252672-mini-review-macroscopic-subtypes-of-hepatocellular-carcinoma-05-15.mp3" length="3837175" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14252672</guid>
    <pubDate>Fri, 05 Jan 2024 08:00:00 -0500</pubDate>
    <itunes:duration>317</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Features of Adenoma-Like Colorectal Adenocarcinoma (03:03)</itunes:title>
    <title>Synopsis: Features of Adenoma-Like Colorectal Adenocarcinoma (03:03)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/  Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, a...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p> <b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p> <b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14225136-synopsis-features-of-adenoma-like-colorectal-adenocarcinoma-03-03.mp3" length="2223744" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14225136</guid>
    <pubDate>Sun, 31 Dec 2023 08:00:00 -0500</pubDate>
    <itunes:duration>183</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Pancreatic Intraductal Tubulopapillary Neoplasm (ITPN) (01:45)</itunes:title>
    <title>Synopsis: Pancreatic Intraductal Tubulopapillary Neoplasm (ITPN) (01:45)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/  Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, a...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p> <b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p> <b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14218156-synopsis-pancreatic-intraductal-tubulopapillary-neoplasm-itpn-01-45.mp3" length="1297213" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14218156</guid>
    <pubDate>Fri, 29 Dec 2023 06:00:00 -0500</pubDate>
    <itunes:duration>105</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Synopsis: Intraductal Oncocytic Papillary Neoplasm (IOPN) of the Pancreatobiliary System (03:37)</itunes:title>
    <title>Synopsis: Intraductal Oncocytic Papillary Neoplasm (IOPN) of the Pancreatobiliary System (03:37)</title>
    <itunes:summary><![CDATA[Feature Summary of IOPN  1. A unique and rare intraductal papillary neoplasm of the pancreaticobiliary system.  2. confluent papillary growth of oncocytic cells with ample eosinophilic cytoplasm. 3. Usually high-grade dysplasia, and 30% of cases harbor invasive carcinoma.   4. Positive for CD117 is a unique feature. 5. Also positive for Muc-1, Muc-5AC and Muc-6.  6. PRKACA-B gene fusion is a distinct genetic hallmark.   7. Extremely favorable survival outcome after resecti...]]></itunes:summary>
    <description><![CDATA[<p><b>Feature Summary of IOPN </b><br/>1. A unique and rare intraductal papillary neoplasm of the pancreaticobiliary system. <br/>2. confluent papillary growth of oncocytic cells with ample eosinophilic cytoplasm.<br/>3. Usually high-grade dysplasia, and 30% of cases harbor invasive carcinoma.  <br/>4. Positive for CD117 is a unique feature.<br/>5. Also positive for Muc-1, Muc-5AC and Muc-6. <br/>6. PRKACA-B gene fusion is a distinct genetic hallmark.  <br/>7. Extremely favorable survival outcome after resection.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Feature Summary of IOPN </b><br/>1. A unique and rare intraductal papillary neoplasm of the pancreaticobiliary system. <br/>2. confluent papillary growth of oncocytic cells with ample eosinophilic cytoplasm.<br/>3. Usually high-grade dysplasia, and 30% of cases harbor invasive carcinoma.  <br/>4. Positive for CD117 is a unique feature.<br/>5. Also positive for Muc-1, Muc-5AC and Muc-6. <br/>6. PRKACA-B gene fusion is a distinct genetic hallmark.  <br/>7. Extremely favorable survival outcome after resection.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14213272-synopsis-intraductal-oncocytic-papillary-neoplasm-iopn-of-the-pancreatobiliary-system-03-37.mp3" length="2636639" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14213272</guid>
    <pubDate>Thu, 28 Dec 2023 07:00:00 -0500</pubDate>
    <itunes:duration>217</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Snippets: Pulmonary Small- vs Large-cell Neuroendocrine Carcinoma by IHC. (02:20)</itunes:title>
    <title>Snippets: Pulmonary Small- vs Large-cell Neuroendocrine Carcinoma by IHC. (02:20)</title>
    <itunes:summary><![CDATA[Key Point Small-cell (neuroendocrine) carcinoma tends to be Rb1-negative and cyclin D1-negative, while large-cell carcinomas are largely positive for Rb1 and/or cyclin D1. The use of this simplified expression pattern leads to a diagnostic accuracy of 97.3%.   ]]></itunes:summary>
    <description><![CDATA[<p><b>Key Point</b><br/>Small-cell (neuroendocrine) carcinoma tends to be Rb1-negative and cyclin D1-negative, while large-cell carcinomas are largely positive for Rb1 and/or cyclin D1. The use of this simplified expression pattern leads to a diagnostic accuracy of 97.3%.  </p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Point</b><br/>Small-cell (neuroendocrine) carcinoma tends to be Rb1-negative and cyclin D1-negative, while large-cell carcinomas are largely positive for Rb1 and/or cyclin D1. The use of this simplified expression pattern leads to a diagnostic accuracy of 97.3%.  </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14196661-snippets-pulmonary-small-vs-large-cell-neuroendocrine-carcinoma-by-ihc-02-20.mp3" length="1706857" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14196661</guid>
    <pubDate>Sat, 23 Dec 2023 12:00:00 -0500</pubDate>
    <itunes:duration>140</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Snippets: Elastin Staining in Resected Colorectal Cancer (02:20)</itunes:title>
    <title>Snippets: Elastin Staining in Resected Colorectal Cancer (02:20)</title>
    <itunes:summary><![CDATA[Key Point Routine elastin staining allows for superior detection and prognostication of vascular invasion in colorectal cancer compared to H&amp;E alone, with a two to threefold increase in vascular invasion detection with elastin stains. ]]></itunes:summary>
    <description><![CDATA[<p><b>Key Point</b><br/>Routine elastin staining allows for superior detection and prognostication of vascular invasion in colorectal cancer compared to H&amp;E alone, with a two to threefold increase in vascular invasion detection with elastin stains.</p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Point</b><br/>Routine elastin staining allows for superior detection and prognostication of vascular invasion in colorectal cancer compared to H&amp;E alone, with a two to threefold increase in vascular invasion detection with elastin stains.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14196640-snippets-elastin-staining-in-resected-colorectal-cancer-02-20.mp3" length="1712152" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14196640</guid>
    <pubDate>Sat, 23 Dec 2023 12:00:00 -0500</pubDate>
    <itunes:duration>140</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Snippets: Epithelial Slackening in Endometrioid Carcinoma (01:39)</itunes:title>
    <title>Snippets: Epithelial Slackening in Endometrioid Carcinoma (01:39)</title>
    <itunes:summary><![CDATA[For the transcript, the key references, and more, please visit us at: http://www.essentialpathology.info/  Disclaimer: The content of "The Diagnostic Minute" is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, a...]]></itunes:summary>
    <description><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p> <b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></description>
    <content:encoded><![CDATA[<p>For the transcript, the key references, and more, please visit us at: <a href='http://www.essentialpathology.info/'>http://www.essentialpathology.info/</a></p><p> <b>Disclaimer:</b> The content of &quot;The Diagnostic Minute&quot; is intended for educational and training purposes only. Listeners assume full responsibility for their use of the information provided in the podcast and agree to use it at their own risk. By accessing the podcast, listeners agree to hold harmless EssentialPathology, NNMI, LLC, and its affiliates, from any and all claims, damages, and expenses arising from the use or misuse of the information provided in the podcast.</p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14191722-snippets-epithelial-slackening-in-endometrioid-carcinoma-01-39.mp3" length="1236934" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14191722</guid>
    <pubDate>Fri, 22 Dec 2023 06:00:00 -0500</pubDate>
    <itunes:duration>100</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Snippets: Lung Adenocarcinoma, grading &amp; Behavior (02:25)</itunes:title>
    <title>Snippets: Lung Adenocarcinoma, grading &amp; Behavior (02:25)</title>
    <itunes:summary><![CDATA[Summary   Lung adenocarcinoma grading is based on the predominant histological pattern. Immunophenotypes also reflect tumor behavior, but these immunophenotypic features are not incorporated in the current grading schema.  ]]></itunes:summary>
    <description><![CDATA[<p>S<b>ummary  </b><br/>Lung adenocarcinoma grading is based on the predominant histological pattern. Immunophenotypes also reflect tumor behavior, but these immunophenotypic features are not incorporated in the current grading schema. </p>]]></description>
    <content:encoded><![CDATA[<p>S<b>ummary  </b><br/>Lung adenocarcinoma grading is based on the predominant histological pattern. Immunophenotypes also reflect tumor behavior, but these immunophenotypic features are not incorporated in the current grading schema. </p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14179525-snippets-lung-adenocarcinoma-grading-behavior-02-25.mp3" length="1771070" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14179525</guid>
    <pubDate>Wed, 20 Dec 2023 06:00:00 -0500</pubDate>
    <itunes:duration>145</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mini-Review: Assessment of Mucosal Mast Cells in Gastrointestinal Tract (04:25)</itunes:title>
    <title>Mini-Review: Assessment of Mucosal Mast Cells in Gastrointestinal Tract (04:25)</title>
    <itunes:summary><![CDATA[Key Points of the Mini-Review Mucosal mast cell assessment for unexplained GI symptoms or suspected systemic mastocytosis.In systemic mastocytosis, 62% exhibit endoscopic abnormalities; 66% biopsies confirm involvement (colon, ileum, duodenum).Specific architectural patterns and high mast cell counts support systemic GI mastocytosis.Clinical indications for assessment: Suspected systemic mastocytosis, unclear symptoms with abnormal endoscopic findings, markedly elevated serum IgE levels.  ]]></itunes:summary>
    <description><![CDATA[<p><b>Key Points of the Mini-Review</b></p><ul><li>Mucosal mast cell assessment for unexplained GI symptoms or suspected systemic mastocytosis.</li><li>In systemic mastocytosis, 62% exhibit endoscopic abnormalities; 66% biopsies confirm involvement (colon, ileum, duodenum).</li><li>Specific architectural patterns and high mast cell counts support systemic GI mastocytosis.</li><li>Clinical indications for assessment: Suspected systemic mastocytosis, unclear symptoms with abnormal endoscopic findings, markedly elevated serum IgE levels.</li></ul><p><br/></p>]]></description>
    <content:encoded><![CDATA[<p><b>Key Points of the Mini-Review</b></p><ul><li>Mucosal mast cell assessment for unexplained GI symptoms or suspected systemic mastocytosis.</li><li>In systemic mastocytosis, 62% exhibit endoscopic abnormalities; 66% biopsies confirm involvement (colon, ileum, duodenum).</li><li>Specific architectural patterns and high mast cell counts support systemic GI mastocytosis.</li><li>Clinical indications for assessment: Suspected systemic mastocytosis, unclear symptoms with abnormal endoscopic findings, markedly elevated serum IgE levels.</li></ul><p><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2173407/episodes/14165431-mini-review-assessment-of-mucosal-mast-cells-in-gastrointestinal-tract-04-25.mp3" length="3228120" type="audio/mpeg" />
    <itunes:author>EssentialPathology, NNMI</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14165431</guid>
    <pubDate>Mon, 18 Dec 2023 07:00:00 -0500</pubDate>
    <itunes:duration>266</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
</channel>
</rss>
